1
                       SECURITIES AND EXCHANGE COMMISSION

                              WASHINGTON, DC 20549

                                    FORM 10-K

(Mark One)

[X]      ANNUAL REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

         For the fiscal year ended December 31, 1997

                                       OR

[ ]      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

         For the transition period from ____________ to ____________


                         Commission file number 1-12626


                            EASTMAN CHEMICAL COMPANY
             (Exact name of registrant as specified in its charter)


                 DELAWARE                                   62-1539359
       (State or other jurisdiction of                    (I.R.S. employer
       incorporation or organization)                    identification no.)

           100 N. EASTMAN ROAD
           KINGSPORT, TENNESSEE                                 37660
 (Address of principal executive offices)                     (Zip Code)


Registrant's telephone number, including area code:  (423) 229-2000



Securities registered pursuant to Section 12(b) of the Act:


                                                        
               Title of each class                          Name of each exchange on which registered
   Common Stock, par value $0.01 per share                             New York Stock Exchange
     (including rights to purchase shares of
Common Stock or Participating Preferred Stock)






Securities registered pursuant to Section 12(g) of the Act:  None



- -------------------------------------------------------------------------------

                 PAGE 1 OF 112 TOTAL SEQUENTIALLY NUMBERED PAGES
                            EXHIBIT INDEX ON PAGE 65


   2



Indicate by check mark whether the registrant: (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.
Yes___X____ No________

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405
of Regulation S-K is not contained herein, and will not be contained, to the
best of registrant's knowledge, in definitive proxy or information statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form 10-K. [X]

The aggregate market value (based upon the closing price on the New York Stock
Exchange on January 30, 1998) of the voting stock held by nonaffiliates was
approximately $4,654,265,390 as of January 31, 1998, using beneficial
ownership rules adopted pursuant to Section 13 of the Securities Exchange Act of
1934 to exclude stock that may be beneficially owned by directors, executive
officers, or 10% shareowners, some of whom might not be held to be affiliates
upon judicial determination. At January 31, 1998, 78,445,546 shares of Common
Stock of the registrant were outstanding.

                       DOCUMENTS INCORPORATED BY REFERENCE

Portions of the registrant's definitive Proxy Statement relating to the 1998
Annual Meeting of Shareowners (the "1998 Proxy Statement"), to be filed with the
Securities and Exchange Commission, are incorporated by reference in Part III,
Items 10-12 of this Annual Report on Form 10-K as indicated herein.

                           FORWARD-LOOKING STATEMENTS

Forward-looking statements appear throughout this report. These statements
relate to planned capacity increases and capital spending; expected tax rates
and depreciation; environmental matters; the year 2000 issue; legal proceedings;
the Asian financial crisis; supply and demand, volume, price, margin, and sales
and earnings expectations and strategies for individual products, businesses,
and segments as well as for the whole of Eastman Chemical Company; cost
reduction targets; and development, production, commercialization, and
acceptance of new products and technologies. These plans and expectations are
based upon certain underlying assumptions, including those mentioned within the
text of this report. Such assumptions are in turn based upon internal estimates
and analyses of current market conditions and trends, management plans and
strategies, economic conditions, and other factors. These plans and expectations
and the assumptions underlying them are necessarily subject to risks and
uncertainties inherent in projecting future conditions and results. Actual
results could differ materially from expectations expressed in the forward-
looking statements if one or more of the underlying assumptions and expectations
proves to be inaccurate or are unrealized.


                                       2


   3


                                TABLE OF CONTENTS


- ---------------------------------------------------------------------------------------------------------

     ITEM                                                                                           PAGE
- ---------------------------------------------------------------------------------------------------------

                                                  PART I

                                                                                              
     1.    Business                                                                               4 - 14
           Executive Officers of the Company                                                          15

     2.    Properties                                                                                 16

     3.    Legal Proceedings                                                                          17

     4.    Submission of Matters to a Vote of Security Holders                                        17


                                                  PART II

     5.    Market for the Registrant's Common Stock and Related Shareowner Matters                    18

     6.    Selected Financial Data                                                                    19

     7.    Management's Discussion and Analysis of Financial Condition and Results
           of Operations                                                                           20-30

     8.    Financial Statements and Supplementary Data                                             31-59

     9.    Changes in and Disagreements With Accountants on Accounting and
           Financial Disclosure                                                                       60


                                                 PART III

     10.   Directors and Executive Officers of the Registrant                                         61

     11.   Executive Compensation                                                                     61

     12.   Security Ownership of Certain Beneficial Owners and Management                             61

     13.   Certain Relationships and Related Transactions                                             61


                                                  PART IV

     14.   Exhibits, Financial Statement Schedules, and Reports on Form 8-K                           62


                                                SIGNATURES

           Signatures                                                                              63-64



                                      3
                                      
   4


                                     PART I

ITEM 1.      BUSINESS

GENERAL

Eastman Chemical Company ("Eastman" or the "Company") is a leading international
chemical company with a broad portfolio of plastic, chemical, and fiber
products. The Company manufactures and sells polyester plastics such as
polyethylene terephthalate ("PET"), a plastic widely used in beverage and food
containers; coatings and paint raw materials; industrial and fine chemicals; and
acetate tow. The Company believes it has a competitive advantage in several
product areas due to its high level of manufacturing integration, the use of
state of the art process technologies and its operating efficiencies due to its
large-scale plants. In 1997 the Company had sales of $4.68 billion, operating
earnings of $506 million, net earnings of $286 million, and basic earnings per
share of $3.66.

The Company began business in 1920 for the purpose of producing chemicals for
Eastman Kodak Company's ("Kodak") photographic business. As of December 31,
1993, the Company became an independent entity when Eastman Kodak Company spun
off its chemical business. Today, the Company is one of the largest chemical
producers in the United States and a leader in the application of several
manufacturing technologies. The Company pioneered the application of coal
gasification technology for the production of chemicals (also referred to as
"chemicals from coal technology") and currently operates one of the largest coal
gasification facilities in the United States, thereby reducing the Company's
dependence on petrochemicals in the manufacture of acetate tow, certain
plastics, and other chemicals. The Company is also a leader in the manufacture
of oxo chemicals that are used in the production of numerous coatings and resin
intermediates, the manufacture of fine chemicals used in photographic and other
custom chemicals, and the application of advanced environmental waste management
practices for chemical manufacturing operations. The Company is a world leader
in developing end-use applications for and recycling of a wide variety of
polyester plastics, including PET and other flexible packaging materials.

The Company categorizes its business into three segments, Specialty and
Performance, Core Plastics, and Chemical Intermediates. See Part II--Item
8--Financial Statements and Supplementary Data--Note 15 to the Consolidated
Financial Statements. The Specialty and Performance segment includes plastic,
chemical, and fiber products primarily sold in diverse markets to customers that
base their buying decisions principally on a product's performance attributes.
The Core Plastics segment includes the Company's major plastics products,
EASTAPAK polymers polyester packaging plastic, TENITE, EASTACOAT, MXSTEN and
TENITE HIFOR polyethylenes, as well as cellulose esters and polyesters. These
container and packaging products share similar physical characteristics and
compete based on price and integrated manufacturing capabilities. The Chemical
Intermediates segment contains industrial intermediate chemical products that
are sold to customers operating in mature markets in which multiple sources of
supply exist. Proprietary products and low-cost manufacturing positions are the
foundation of the Chemical Intermediates segment. Eastman's strategy is to
manage the mix between Specialty and Performance, Core Plastics, and Chemical
Intermediates products to fully utilize its plants and obtain optimum
profitability. The Company has the capability to produce a wide range of
products within its manufacturing plant capacities and change product mix
depending on customer demand and the Company's strategy.


                                        4



   5


The following table summarizes the Company's recent financial performance and
identifiable assets by industry segment.




SEGMENT FINANCIAL SUMMARY
(Dollars in millions)
                                                   1997           1996          1995
                                                                             
 SALES
   Specialty and Performance                     $ 2,607        $ 2,657        $ 2,647   
   Core Plastics                                   1,338          1,409          1,685   
   Chemical Intermediates                            733            716            708   
                                                 -------        -------        -------   
     Total                                       $ 4,678        $ 4,782        $ 5,040   
                                                 =======        =======        =======
                                                                                         
OPERATING EARNINGS (LOSS)                                                                
   Specialty and Performance                     $   416(1)     $   519        $   433   
   Core Plastics                                     (56)(1)         (1)           347   
   Chemical Intermediates                            146(1)         145            184   
                                                 -------        -------        -------   
     Total                                       $   506        $   663        $   964   
                                                 =======        =======        =======
                                                                                         
 ASSETS                                                                                  
   Specialty and Performance                     $ 3,019        $ 2,887        $ 2,776   
   Core Plastics                                   2,188          1,854          1,598   
   Chemical Intermediates                            571            525            498   
                                                 -------        -------        -------   
     Total                                       $ 5,778        $ 5,266        $ 4,872   
                                                 =======        =======        =======


(1) Operating earnings for 1997 reflect the effect of a $62 million ($40 million
after tax) charge for partial settlement/curtailment of pension and other
postemployment benefit liabilities. This charge was allocated to segments as
follows: Specialty and Performance, $34 million; Core Plastics, $18 million; and
Chemical Intermediates, $10 million. See Note 14 to Consolidated Financial
Statements. 

BUSINESS STRATEGY

Eastman's business strategy is to achieve consistent, profitable growth as a
highly integrated, international supplier of a diversified portfolio of
plastics, chemicals, and fibers. Specifically, the Company's strategic intent is
"To Be The World's Preferred Chemical Company." The following are the key
elements the Company employs to achieve this strategy:

Proprietary Products and Core Competencies

The Company has developed its broad chemical product line through the
application of three major areas of technical strength referred to by the
Company as technology core competencies: polymer technology, organic chemistry
technology, and cellulose technology. The polymer core competence includes
polyester, polyolefin, and other polymer technologies, and forms the technical
basis of the Company's polyester and polyethylene product lines. The organic
chemistry core competence includes coal gasification for chemicals, oxo
chemistry, and complex organic chemistry technologies, and forms the basis of
the Company's fine chemical and intermediate chemical product lines. The
cellulose core competence includes cellulose conversion to acetate fibers and
plastic manufacturing technologies, and forms the basis of the Company's acetate
fibers and cellulose plastic product lines. The Company has developed or
acquired proprietary technologies and know-how with respect to each of these
core competencies. The Company's ongoing product development strategy is to
build on existing technology core competencies and develop new technology core
competencies.


                                        5



   6


Manufacturing Integration and Scale

The Company's strategy is to continue to use integration of its manufacturing
plants to develop a competitive advantage. This integration provides the Company
with cost efficient and flexible manufacturing operations. The Company's major
manufacturing plants are highly integrated. Intermediate chemicals produced at
one plant are frequently distributed between plants to produce other plastics
and chemicals. Starting with a limited number of basic raw materials, primarily
coal, ethane and propane, cellulose, ethylene glycol, paraxylene and other basic
chemicals, the Company uses its integrated manufacturing capabilities to produce
more than 400 major products.

Through its development of highly integrated manufacturing, Eastman has the
capability to safely and efficiently operate large-scale chemical plants,
including one of the world's largest integrated chemical plants in Kingsport,
Tennessee. The Company's development efforts include the continual improvement
of these operations to achieve capacity increases and other earnings enhancement
projects with relatively low capital expenditures.

Quality Management

Quality Management is a fundamental set of operating and management principles
that are an extension of the philosophy of the Company's founder, George
Eastman. During the last fourteen years, the Company has further developed these
principles into its current Quality Policy. This policy states the Company's
goal to be the leader in quality and value of products and services, by focusing
on customers, process control, continual improvement, and innovation. The
Company's highly integrated manufacturing operations support the Company's total
quality policy by providing internal control of intermediate raw material
processes. The Company's success in fostering this total quality policy is
evidenced by the U.S. Commerce Department's selection of the Company as the
recipient of the 1993 Malcolm Baldrige National Quality Award in the large
manufacturing category.

The Company has 12 quality system registrations to the international quality
standard, ISO 9000. Ten of these are in North America and two are in the United
Kingdom. Approximately three-fourths of 1997 sales were from products
manufactured in ISO 9000 registered quality systems.

Expansion in International Markets

Approximately 41% of the Company's customers representing 39% of the Company's
sales were outside the United States in 1997. This growth in worldwide sales
over the past few years and achievement of satisfactory returns is primarily due
to its efficient large-scale plants in the United States and increasing
expansion of manufacturing facilities in strategic global locations. The Company
has facilities in Hartlepool and Workington, England, for the manufacture of
polyester, used to produce film, bottles, and other packaging. The Workington
site also produces acetate tow. In addition, the Company's operations include a
polyester manufacturing facility in Toronto, Canada; EASTAPAK polymers plants in
Cosoleacaque, Veracruz, Mexico and San Roque, Spain; and facilities in the
United Kingdom and Hong Kong for the manufacture of fine chemicals.

The Company is increasing its international manufacturing presence by targeting
a higher percentage of its annual capital expenditures for markets outside the
United States. The Company is building EASTAPAK polymers plants in the
Netherlands and Argentina, with operational dates of 1998. Construction is also
underway on an additional plant in the Netherlands to produce purified
terephthalic acid ("PTA"), a key raw material for the production of EASTAPAK
polymers, with an operational date of 1998. A newly constructed facility located
in Kuantan, Malaysia, will produce 30,000 metric tons of copolyester when it
becomes operational in 1998. In addition, the Company has begun construction of
a new oxo chemicals manufacturing complex in Singapore, with production expected
in early 1999, and is studying the feasibility of forming a joint venture in
Nanjing, People's Republic of China, to produce hydrocarbon tackifying resins.

The Company has increased its international sales and distribution
infrastructure during the past several years to position it for worldwide sales
growth. In particular, from 1990 through 1997, the Company increased personnel
outside the United States from approximately 500 to nearly 1,800 employees.
During the same time period, the number of Company sales offices outside the
United States increased from 25 to 36 in a total of 32


                                        6

   7



countries. For financial information about foreign and domestic operations and
export sales, see Part II--Item 8--Financial Statements and Supplementary
Data--Note 15 to Consolidated Financial Statements.

The Company's current and future business expansions in international markets
are dependent on projected regional economic conditions. Generally, the Company
uses its international marketing organizations to sell into international
markets. After achieving sufficient sales levels and developing an understanding
of the markets and earnings potential, the Company may invest in manufacturing
capacity appropriate to serve the region, taking into account the projected
future business conditions in the region. See Part II--Item 7--"Management's
Discussion and Analysis of Financial Condition and Results of Operations-Results
of Operations--Summary by Customer Location" for a discussion of certain risks
to which the Company is subject as a result of its operating in international
markets.

Strategic Market Orientation

The Company's organization is aligned to focus on strategic markets. The Company
believes that its market focus helps sustain earnings during economic downturns
and allows it to focus on growth.

Employee Ownership and Incentives

The Company believes that employee stock ownership will be a significant factor
in achieving its goal of consistent, profitable growth. The Eastman Employee
Stock Ownership Plan ("ESOP") is intended to foster employee ownership
throughout the Company, and stock ownership guidelines have been established for
the Company's directors and approximately 600 key Company managers. All Eastman
employees have placed at risk approximately 5% of their overall pay under the
Eastman Performance Plan, an annual incentive plan that rewards employees based
on the Company's achieved return on capital in relation to its cost of capital.
A certain portion of the incentive pay (approximately 5% of eligible employees'
annual pay in 1997, 1996, and 1995) has been made in the form of a contribution
by the Company of Eastman common stock under the ESOP. An additional portion of
management compensation is tied to Company performance under the Eastman Annual
Performance Plan. For further information concerning the Company's ESOP and
incentive pay plans, see Part II--Item 8--Financial Statements and Supplementary
Data--Note 8 to Consolidated Financial Statements and Part III--Item
11--Executive Compensation.

INDUSTRY SEGMENTS

SPECIALTY AND PERFORMANCE SEGMENT

The key product groupings and primary markets in the Specialty and Performance
segment are summarized as follows:



          Product Groupings                                     Primary Markets
- ------------------------------------------- ----------------------------------------------------------
                                         
Fibers                                      Filters and Fabrics

Coatings, inks, and resins                  Coatings, inks and paints

Fine chemicals                              Photographic and custom chemicals
                                            Pharmaceutical and agricultural intermediates

Performance chemicals                       Additives for fibers and plastics, semi-conductors
                                            Adhesives and sealants
                                            Food and beverages
                                            Nutrition, cosmetics, construction
                                            Textiles

Specialty plastics                          Medical, electronics, recreation, consumer durables
                                            Plastic packaging



                                        7


   8


Fibers

The Company is one of the world's largest suppliers of cellulose acetate tow, a
product developed by the Company in the 1950's that is used by our customers
primarily in the manufacture of cigarette filters. With approximately 400
million pounds of annual capacity at its plants in Kingsport, Tennessee, and
Workington, England, the Company accounts for approximately 30% of the annual
worldwide production of acetate tow, and sells to all major cigarette producers
throughout the world. The two primary raw materials used in the manufacture of
acetate tow are cellulose (from wood pulp) and acetic anhydride. The Company has
developed the world's only commercial coal gasification facility to produce the
latter. This facility reduces the Company's dependency on petrochemicals
otherwise required for the manufacture of acetate tow.

Competition for sales of acetate tow is based on price, product quality, and
reliability of supply. The Company believes that it enjoys a low-cost position
for raw materials as a result of its coal gasification technology, efficient
integrated manufacturing processes, and overall size.

Growth in the acetate tow market is directly related to the level of filtered
cigarette consumption, which continues to increase worldwide despite declining
levels of cigarette consumption in North America. Historically, worldwide
industry sales volume growth has averaged between 2% - 3% per year. In 1995 and
1996 worldwide growth in the market for acetate tow, led primarily by sales to
China, resulted in higher levels of capacity utilization for both the Company
and the industry. During 1997, industry capacity utilization declined somewhat
due to new domestic production facilities beginning operation in China,
resulting in lower sales of and lower operating earnings for acetate tow. The
Company expects very modest growth in worldwide demand for acetate tow over the
long term.

Acetate yarn is produced by the Company for the textile industry. Product price,
quality, and service are the primary factors influencing customer-purchasing
decisions. This product line utilizes the Company's basic cellulose technology
core competence along with its large cellulose acetate manufacturing position to
compete effectively. The market for acetate yarn has experienced essentially no
growth during recent years, and, in fact, declined somewhat during 1997. The
Company has focused its efforts on improving its operating efficiencies to
maintain its product quality and cost position.

Fibers products accounted for approximately 28% of 1997 Specialty and
Performance segment sales.

Coatings, inks, and resins

The Company supplies a wide variety of raw materials and intermediate products
to the coatings, inks, and resins markets, including solvents, alcohols,
glycols, and resins. All of the Company's coatings, inks, and resins products
are currently produced in the United States with a majority of 1997 sales being
in the United States and the remainder worldwide. Most of the products in this
area are olefin or cellulose derivatives and utilize the Company's proprietary
oxo chemistry technology or chemicals-from-coal technology. Products include
mixed cellulose esters, of which the Company is the world's only manufacturer.
Competitive suppliers of products into the coatings, inks, and resins markets
compete based on price, breadth of product line, reliability of supply, and
customer service. The Company believes it has a competitive advantage due to the
efficiency of its proprietary oxo chemistry technology and chemicals-from-coal
technology, the breadth of its product line, and its system of distribution.
Products sold in these markets accounted for approximately 26% of 1997 Specialty
and Performance segment sales.



                                        8


   9


Specialty plastics

Specialty plastics are produced by the Company for value-added end uses, such as
toothbrushes, eyeglass frames, medical devices, electrical connectors, tools,
appliance housings, food and medical packaging, heavy-gauge sheeting, and
fabricated boxes. The plastics supplied for these end uses include polyethylene,
polyester/copolyesters, cellulosics, and alloys of two or more plastics combined
to provide specific performance characteristics. The Company's strategy for
these products is to identify and serve selected niche markets that offer the
potential for attractive returns. Suppliers of specialty plastics products
compete based on price, product performance, reliability of supply, product
differentiation, and customer service. The Company believes it has a competitive
advantage due to its product performance, its systems of marketing and
distribution, and efficiency of its specialized copolyester chemistry and
cellulose technology. Specialty plastics accounted for approximately 19% of 1997
Specialty and Performance segment sales.

Fine chemicals

Fine chemicals produced by Eastman are used in the manufacture of a wide variety
of products such as photographic products, home care products, and custom
chemicals. The Company is a leading producer of custom chemicals used in the
manufacture of pharmaceuticals and agricultural chemicals, and of other products
synthesized to customer specifications. Technical competence and efficiency are
major competitive elements in the fine chemicals industry. The Company believes
it has a competitive advantage because of its competency in complex multi-step
organic chemistry and the breadth of services offered in custom manufacturing
(i.e., regulatory compliance and process design and optimization). During 1997,
fine chemicals accounted for approximately 15% of Specialty and Performance
segment sales.

Performance chemicals

Eastman produces a variety of additives for fibers and plastics, raw materials
for adhesives and sealants, food and beverage ingredients, and other performance
products. Fiber and plastic additives are used to impart specialized processing
and performance characteristics to polymers used in the production of a range of
fibers and plastics products. The Company produces raw materials for adhesives
that are used in hot-melt and pressure-sensitive applications. Eastman is a
manufacturer of natural and synthetic food-grade antioxidants that are used to
enhance the stability and extend the shelf life of many products containing oils
and fats. Eastman is the only U.S. producer of sorbates that are used as food
and cosmetic preservatives because of their antimicrobial action. The Company
also manufactures many other performance products for use in nutrition,
cosmetic, textile and construction applications.

The Company believes it has a competitive advantage in many of the markets in
which these performance products are sold. Many proprietary products with highly
recognized trade names deliver to customers high quality and unique performance
attributes. Competitors and competitive conditions vary depending on the market
segment. During 1997, performance chemicals accounted for approximately 12% of
Specialty and Performance segment sales.


                                        9



   10


CORE PLASTICS SEGMENT

The key product groupings and the primary markets in the Core Plastics segment
are summarized as follows:



                               
          Product Groupings                Primary Markets
- --------------------------------- -------------------------------------------

Container plastics                Soft drink, food and water containers

Flexible plastics                 Packaging
                                  Photographic
                                  Fibers


Container plastics

The Company is the world's leading supplier of polyester plastics, including
EASTAPAK polymers (PET), for packaging applications, with the majority of its
sales concentrated in North America, Europe, and Latin America. The market for
polyester plastics has experienced significant growth in recent years due to the
substitution of these plastics for other packaging materials used in soft drink,
food, and water containers. Industry estimates indicate that PET consumption
grew worldwide from 2.3 billion pounds per year in 1989 to approximately 8.9
billion pounds per year in 1997. Capital expansion projects currently underway
in the Netherlands and Argentina will add approximately 600 million pounds of
additional PET capacity by the end of 1998. Overcapacity worldwide continues to
pressure PET selling prices.

Competition for the large volume PET market is based largely on price and
service. Management believes that the Company's large-scale operations, vertical
integration, and manufacturing expertise provide it with a competitive advantage
by allowing the Company to position itself as a price-competitive, consistently
reliable source of supply across a broad product line. In addition, the Company
has developed proprietary polyester polymers that enable it to respond to
specific customer design and performance requirements, and is a leader in the
manufacture of recycled-content PET. Container plastics products accounted for
approximately 62% of 1997 Core Plastics segment sales.

Flexible plastics

The Company manufactures a variety of plastics including polyethylene, cellulose
esters, and polyesters for applications such as film, extrusion coating, fibers,
tape, industrial strapping, and injection molding. The polyethylene product line
includes low density, linear low density, and medium/high density polymers. The
markets for these polyethylene products are characterized generally as large
volume with a large number of customers and suppliers. The Company competes
based on its integrated manufacturing capabilities and, in some of these market
areas, on the basis of unique product characteristics. Several of the Company's
competitors are larger, with some having a higher degree of vertical
integration. As a result of the Company's position in the overall polyethylene
market, the strategy is to focus on selected markets based on the Company's
ability to produce high quality performance polymers. In addition to
polyethylenes, the Company's strong core competency in cellulose esters and
polyesters allows it to offer a wide range of differentiated high performance
polymers in selected fiber and film markets. Flexible plastics accounted for
approximately 38% of 1997 Core Plastics segment sales.


                                       10

   11


CHEMICAL INTERMEDIATES SEGMENT

The key product grouping and the primary markets in the Chemical Intermediates
segment are summarized as follows:



                                

          Product Groupings                 Primary Markets
- ---------------------------------- -------------------------------------------

Industrial intermediates           Industrial additives
                                   Agricultural chemicals
                                   Pharmaceuticals
                                   Vinyl compounding
                                   Wood and metal coatings
                                   Artificial sweeteners


Industrial Intermediates

Industrial intermediate chemicals are produced based on the Company's oxo
chemistry technology and chemicals-from-coal technology. These products include
basic acetyl, oxo chemicals, and plasticizers, and are marketed to customers
producing esters, polymers, industrial additives, agricultural chemicals,
industrial intermediates, monomers and polymers, medical delivery equipment, and
pharmaceuticals. In 1997 approximately 76% of these products were sold in the
United States with the remainder sold internationally. Volume growth rates of
these chemicals tend to follow the growth in the world economy.

Competition in the market for industrial intermediate chemicals is based on
price, customer relationships, and reliability of supply. The Company's
large-scale integrated manufacturing provides the Company with a low-cost
position in several of these products. In addition, the Company is able to
provide its customers with a reliable source of supply through an extensive
distribution network.

RAW MATERIALS

The Company purchases substantially all of its key raw materials under long-term
contracts, generally of three to five years initial duration with renewal
provisions. Most of those agreements do not require the Company to buy materials
if its operations are shut down or if the Company's demand is otherwise reduced.
Key raw materials purchased include cellulose, ethylene glycol, paraxylene,
purified terephthalic acid ("PTA"), coal, ethane, and propane. The Company has
multiple suppliers for most key raw materials and uses quality management
principles, such as the establishment of long-term relationships with suppliers
and ongoing performance assessment and benchmarking, as part of the total
supplier selection process.

CAPITAL EXPENDITURES

Total capital expenditures were $749 million in 1997, $789 million in 1996, and
$446 million in 1995. Eastman anticipates that total capital expenditures in
1998 will be between $550 and $600 million. Efficiency of capital utilization is
a key initiative of the Company. The Company uses alliances and joint ventures,
where appropriate, to provide additional capital expansion.

During 1997, 1996, and 1995, the Company made capital expenditures of $70
million, $51 million, and $39 million, respectively, related to environmental
improvements. The Company estimates that such capital expenditures will be
approximately $49 million and $86 million for 1998 and 1999, respectively.
Future expenditures will be dependent in part upon implementation of government
environmental regulations.

DISPOSITIONS

As previously reported, in February 1995 Eastman sold its Kingsport, Tennessee
compounded polypropylene product line. In addition, the Company ceased
production of natural source vitamin E in 1995 and of pigmented inks in 1996,
and sold the food-grade distilled monoglycerides, powder coatings, and adhesives
businesses in 1996 and its polyols business in 1997. The effect of these
divestitures and product discontinuances on financial position and results of
operations has not been, and is not expected to be, material.


                                       11

   12


EMPLOYEE RELATIONS

The Company employs approximately 16,100 men and women worldwide. None of the
employees in the United States and approximately 2% of the total worldwide labor
force are represented by labor unions. The Company believes that its employee
relations are excellent.

CUSTOMER RELATIONS

Eastman has an extensive customer base and, while it is not dependent on any one
customer or group of customers, loss of certain top customers could adversely
affect the Company until such business is replaced. The Company has
approximately 5,300 customers worldwide and the top 100 customers account for
approximately 60% of the Company's business. Eastman's largest customer is
Kodak, which accounted for approximately 5% of total sales in 1997.

The Company has received numerous preferred-supplier awards and is the sole
supplier to several major customers. The Company strives to be the preferred
supplier to customers in the markets it serves.

COMPETITION

The Company's competitive environment varies among markets. Some of the
Company's competitors are larger in size and capital base than the Company.
Major competitors of the Company in its key markets are summarized as follows:



         Key Market                                          Major Competitors
- ------------------------------------------- --------------------------------------------------------------
                                         
Fibers                                      Courtaulds, Daicel, Celanese, Mitsubishi, Novaceta,
                                            Rhone-Poulenc, Teijin

Coatings, inks, and resins                  BASF, Exxon, Celanese, S. C. Johnson, Lonza,
                                            Oxychem, Shell, Union Carbide

Fine chemicals                              DSM, LaPorte, Lonza

Performance chemicals                       AlliedSignal, ARCO, Clariant, Daicel, Dow, Exxon, Hercules,
                                            Nutrinova, Rexene, Rhone-Poulenc, UOP

Specialty plastics                          BASF, Bayer, Dow, DuPont, GE, Hoechst A.G., Phillips, Akzo Nobel,
                                            AtoHaas, ICI, Geon, Shell

Container plastics                          Hoechst Celanese, DuPont, Shell, Wellman, Nan Ya

Flexible plastics                           Chevron, Dow, Exxon, Hoechst Celanese, Mobil, Quantum, Shell,
                                            Union Carbide

Industrial intermediates                    BASF, BP, Dow, Exxon, Celanese Ltd., Rhone-Poulenc, Union Carbide



RESEARCH AND DEVELOPMENT

The Company directs its research and development programs toward four
objectives: 1) continually improving product quality by improvement in
manufacturing technology and processes; 2) lowering manufacturing costs through
process improvement; 3) conducting exploratory research to develop new product
lines and markets; and 4) developing new products and processes that are
compatible with the Company's commitment to RESPONSIBLE CARE (see
"Environmental" section on next page). 


                                       12


   13


Major achievements in research and development during the last several years
include the chemicals-from-coal technology, enhancements of the oxo chemistry
technology, and polyester application development and manufacturing technology.
The Company has developed wastewater treatment technology and technology to
improve PET recycling. Eastman has developed technology that provides a faster,
lower-cost route to production of EpB oxirane, a building block chemical used in
many other chemicals. In addition, the Company has commercialized a group of
new, higher-value polyolefins with increased tear strength and impact
performance--MXSTEN and TENITE HIFOR.

The Company's research and development expenditures during the past five years
have averaged approximately 4% of sales annually with 1997, 1996, and 1995
expenditures totaling $191 million, $184 million, and $176 million,
respectively. Expenditures for 1998 are anticipated to be within the 1996-1997
range.

PATENTS AND TRADEMARKS

The Company owns or licenses a large number of U.S. and non-U.S. patents that
relate to a wide variety of products and processes. Company patents expire at
various times during the next several years. The Company also owns or licenses
trademarks in the U.S. and in foreign countries on major product segments. While
these patents, licenses, and trademarks are considered important, the Company
does not consider its business as a whole to be materially dependent upon any
one particular patent, patent license, or trademark.

SEASONALITY

Seasonality is not a significant factor for the Company, although the Specialty
and Performance segment experiences some seasonal effects during the winter
months because of reduced demand for paint products, and the Core Plastics
segment experiences reduced demand for soft-drink containers during the first
and third quarters.

MARKETING AND DISTRIBUTION

The Company markets products through a worldwide sales organization with 36
sales offices outside the United States in 32 countries. A majority of sales are
direct; however, some sales are made through indirect selling channels. Products
are shipped to customers directly from the Company's plants as well as from
distribution centers, with the method of shipment generally determined by the
customer.

ENVIRONMENTAL

The Company is actively engaged in the ongoing development and enhancement of
products that are environmentally responsible, such as waterborne products and
recyclable plastics. In addition, the Company is an active participant in
RESPONSIBLE CARE, a chemical industry initiative that focuses on improving
performance in areas including community awareness and emergency response,
pollution prevention, process safety, distribution, employee health and safety,
and product stewardship.

Health, safety, and environmental considerations are a priority in the Company's
planning for all existing and new products and processes. The Health, Safety &
Environmental and Public Policy Committee of Eastman's Board of Directors
reviews the Company's policies and practices concerning health, safety, and the
environment, and its processes for complying with related laws and regulations,
and monitors significant related matters. The Company's policy is to operate its
plants and facilities in a manner that protects the environment and the health
and safety of its employees and the public. The Company has made and intends to
continue to make expenditures for environmental protection and improvement in a
timely manner consistent with the foregoing policies and with the technology
available. In some cases, applicable environmental regulations, such as those
adopted under the federal Clean Air Act and the Resource Conservation and
Recovery Act, and related actions of regulatory agencies, determine the timing
and amount of environmental costs incurred by the Company.


                                       13


   14


The Company's commitment to environmental stewardship has earned favorable
recognition. In late 1997, Eastman was recognized by the Chemical Manufacturers
Association for its 1996 energy efficiency efforts. In 1996, Tennessee Eastman
Division's wastewater treatment facility received the Operational Excellence
Award from the Kentucky-Tennessee Water Environment Association and the national
George F. Burke, Jr. Award from the Water Environment Association for operation
safety. During 1995 Eastman received environmental awards from the Chemical
Manufacturers Association, the Kentucky-Tennessee Water Environment Association,
the League of Women Voters of the Texas Education Fund, and the Tennessee
Association of Business.

Certain of the Company's manufacturing sites generate hazardous and nonhazardous
wastes, of which the treatment, storage, transportation, and disposal are
regulated by various governmental agencies. In connection with the cleanup of
various hazardous waste sites, the Company, along with many other entities, has
been designated a potentially responsible party ("PRP") by the U.S.
Environmental Protection Agency under the Comprehensive Environmental Response,
Compensation and Liability Act, which potentially subjects PRPs to joint and
several liability for such cleanup costs. In addition, the Company will be
required to incur costs relating to environmental remediation and
closure/postclosure pursuant to the federal Resource Conservation and Recovery
Act. Because of expected sharing of costs, the availability of legal defenses,
and the Company's preliminary assessment of actions that may be required, the
Company does not believe its liability for these environmental matters,
individually or in the aggregate, will be material to Eastman's consolidated
financial position, results of operations, or competitive position. The
Company's policy is to record such liabilities when loss amounts are probable
and can be reasonably estimated.

The Company's environmental protection and improvement cash expenditures were
approximately $220 million, $175 million, and $150 million in 1997, 1996, and
1995, respectively, including investments in construction, operations, and
development. The Company does not expect future environmental capital
expenditures arising from requirements of recently promulgated environmental
laws and regulations to materially increase the Company's planned level of
capital expenditures for environmental control facilities.

BACKLOG

During 1997, the Company's backlog of firm orders averaged between $200 million
and $400 million, representing two to four weeks' sales. The Company adjusts its
inventory policy to control the backlog of products dependent on customers'
needs. In areas where the Company is the single source of supply, or competitive
forces or customers' needs dictate, the Company may carry additional inventory
to reduce backlog. Backlog is also affected by utilization of a given product
manufacturing capacity.


                                       14



   15


EXECUTIVE OFFICERS OF THE COMPANY

Certain information about the Company's executive officers is provided below:

Earnest W. Deavenport, Jr., age 59, is Chairman of the Board and Chief Executive
Officer of the Company. He joined the Company in 1960. Mr. Deavenport was named
President of the Company in 1989 and also served as Group Vice President of
Kodak from 1989 through 1993.

R. Wiley Bourne, Jr., age 60, is Vice Chairman of the Board and Executive Vice
President of the Company, responsible for all business organizations. He joined
the Company in 1959, was named Executive Vice President in 1989, and also served
as a Vice President of Kodak from 1986 through 1993.

Dr. James L. Chitwood, age 54, is Senior Vice President of the Company,
responsible for operations outside North America. Dr. Chitwood joined the
Company in 1968, was named Senior Vice President of the Company in 1989, and
Group Vice President, Specialty Business Group in 1991. Dr. Chitwood was
appointed Senior Vice President with responsibility for Company business
organizations in October 1994 and assumed his current responsibilities in 1996.
He also served as a Vice President of Kodak from 1984 through 1993.

Harold L. Henderson, age 62, joined the Company in 1997 as Senior Vice President
and General Counsel. Mr. Henderson served previously as chief legal officer of
The Firestone Tire & Rubber Company from 1980 to 1985 and of RJR Nabisco, Inc.
from 1985 to 1989. He was a consultant, commercial real estate developer, and
private investor from 1989 through 1996.

Tom O. Nethery, age 59, is Senior Vice President of the Company, responsible for
functional organizations. Mr. Nethery joined the Company in 1960 and was named
Senior Vice President, Manufacturing of the Company in 1989. He was named Group
Vice President, Industrial Business Group in 1991 and was appointed to his
current position in October 1994. Mr. Nethery also served as a Vice President of
Kodak from 1989 through 1993.

H. Virgil Stephens, age 60, is Senior Vice President and Chief Financial Officer
of the Company. Mr. Stephens joined the Company in 1979. In 1988, Mr. Stephens
was named Vice President, Financial and Information Services, became Vice
President and Chief Financial Officer in 1993, and was appointed to his current
position in 1996. Mr. Stephens has announced his retirement effective April 1,
1998.

Darryl K. Williams, age 55, is Senior Vice President, Technology and Quality, of
the Company. Mr. Williams joined the Company in 1965. He was appointed president
of Eastman Chemical Japan Ltd. in 1992, was named Vice President, Asia Pacific
Regional Support Services in 1993, was appointed Vice President, Asia Pacific
Sales in 1994, and was named Senior Vice President, Technology in 1996. He
assumed his current position in 1998.

Betty W. DeVinney, age 53, is Vice President, Communications and Public Affairs.
Mrs. DeVinney joined the Company in 1973. In 1991, she became Manager,
Employment, was named Manager, Community Relations in 1995 and was appointed
Manager, Corporate Relations in 1997. She assumed her current position in 1998.

Patrick R. Kinsey, age 52, is Vice President and Comptroller of the Company. Mr.
Kinsey joined the Company in 1967, was named Director, Internal Auditing in 1993
and became Director, Corporate Financial Reporting in 1996. He assumed his
current position in 1998.

B. Fielding Rolston, age 56, is Vice President, Human Resources and Health,
Safety, Environment, and Security of the Company. Mr. Rolston joined the Company
in 1964 and was appointed Vice President, Customer Service and Materials
Management of the Company in 1987. He assumed his current position in 1998.

Allan R. Rothwell, age 50, assumed his current position as Vice President,
Corporate Development and Strategy in 1997. In addition to his current
responsibilities, Mr. Rothwell will assume the position of Senior Vice President
and Chief Financial Officer on April 1, 1998, upon the retirement of Mr.
Stephens. Mr. Rothwell joined the Company in 1969 and was appointed Business
Director, Industrial Intermediates in 1993. In 1994, he became Vice President
and General Manager, Container Plastics.


                                       15


   16


ITEM 2.   PROPERTIES

PROPERTIES

A summary of the Company's principal manufacturing sites and the key products
produced at each site is shown in the table below. Eastman's plants generally
are well maintained, are in good operating condition, and are suitable and
adequate for their use. Utilization of these facilities may vary with product
mix, and economic, seasonal, and other business conditions, but none of the
principal plants are substantially idle.

The Company's plants, including approved expansions, generally have sufficient
capacity for existing needs and expected near-term growth.



     Location                                Unit                                Key Products
- ----------------------------   ----------------------------------------      ----------------------------------------
                                                                       
Batesville, AR                 Arkansas Eastman                              Fine Chemicals
Columbia, SC                   Carolina Eastman                              Polyester Polymers
Cosoleacaque, Mexico           Eastman Chemical Industrial de Mexico         Polyester Polymers
Hartlepool, England            Eastman Chemical Ectona, Ltd.                 Polyester Polymers
Hong Kong                      Eastman Chemical Hong Kong, Ltd.              Fine Chemicals
Kingsport, TN                  Tennessee Eastman                             Acetate Tow
                                                                             Coatings and Paint Raw Materials
                                                                             Polyester Polymers
                                                                             Fine Chemicals
Kuantan, Malaysia*             Eastman Chemical Malaysia SDN BHD             Copolyester Plastics
Llangefni, Wales               Eastman Chemical (UK) Limited                 Fine Chemicals
Longview, TX                   Texas Eastman                                 Oxo Chemicals
                                                                             Plastics
Rochester, NY                  Distillation Products Division                Monoglycerides and Antioxidants
Roebuck, SC                    ABCO Industries, Inc.                         Waterborne Polymers
                                                                             Textile Chemicals
Rotterdam, Netherlands*        Eastman Chemical Netherlands B.V.             Polyester Polymers
San Roque, Spain               Eastman Chemical Espana, S.A.                 Polyester Polymers
Singapore*                     Eastman Chemical Singapore Pte. Ltd.          Oxo Chemicals
Toronto, Ontario, Canada       Eastman Chemical Canada, Inc.                 Polyester Polymers
Workington, England            Eastman Chemical Ectona, Ltd.                 Acetate Tow
                                                                             Polyester Polymers
Zarate, Argentina*             Eastman Chemical Argentina S.A.               Polyester Polymers

*Under construction



The Company has a 50% interest in Primester, a joint venture which manufactures
cellulose ester at its Kingsport, Tennessee plant. The production of cellulose
ester is an intermediate step in the manufacture of acetate tow and other
cellulose-based products.

The Company also has a 50% interest in Genencor International, a joint venture
which develops, manufactures and markets industrial enzymes and other fine and
specialty chemicals at numerous international locations.

The Company has distribution facilities at all of its plant sites. In addition,
the Company conducts manufacturing operations at three other sites and operates
81 stand-alone distribution facilities in 18 countries. Corporate headquarters
are in Kingsport, Tennessee. The Company's regional headquarters are in Coral
Gables, Florida; The Hague, Netherlands; Singapore; and Kingsport, Tennessee.
Technical service is provided to the Company's customers from technical service
centers in Kingsport, Tennessee; Kirkby, England; Osaka, Japan; and Singapore.
Customer service centers are located in Kingsport, Tennessee; Rotterdam,
Netherlands; Coral Gables, Florida; and Singapore.


                                       16


   17


ITEM 3.    LEGAL PROCEEDINGS

LEGAL PROCEEDINGS

In May 1997 the Company received notice from the Tennessee Department of
Environment and Conservation ("TDEC") alleging that the manner in which
hazardous waste was fed into certain boilers at the Tennessee Eastman facility
in Kingsport, Tennessee violated provisions of the Tennessee Hazardous Waste
Management Act. Based upon subsequent communications with the TDEC and the U.S.
Environmental Protection Agency, the Company believes that these agencies may be
contemplating enforcement proceedings which, if commenced, could result in
monetary sanctions in excess of the $100,000 threshold of Regulation S-K, Item
103, Instruction 5.C. under the Securities Exchange Act of 1934 for reporting
such contemplated proceedings in this Report.

The Company's operations are parties to or targets of lawsuits, claims,
investigations, and proceedings, including product liability, personal injury,
patent, commercial, contract, environmental, antitrust, health and safety, and
employment matters, which are being handled and defended in the ordinary course
of business. While the Company is unable to predict the outcome of these
matters, it does not believe, based upon currently available facts, that the
ultimate resolution of any of such pending matters, including the TDEC
allegations described in the preceding paragraph, will have a material adverse
effect on the Company's financial position, or results of operations.


ITEM 4.    SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

There were no matters submitted to a vote of the Company's shareowners during
the fourth quarter of 1997.


- --------------------------------------
RESPONSIBLE CARE is a registered service mark of the chemical industry.
EASTAPAK, TENITE, EASTACOAT, MXSTEN, SPECTAR, and TENITE HIFOR are trademarks of
Eastman Chemical Company.


                                       17


   18


                                     PART II

ITEM 5.    MARKET FOR THE REGISTRANT'S COMMON STOCK AND RELATED
           SHAREOWNER MATTERS

The Company's Common Stock is traded on the New York Stock Exchange (the "NYSE")
under the symbol "EMN." The following table presents the high and low sales
prices of the Common Stock on the NYSE and the cash dividends per share declared
by the Company's Board of Directors for each quarterly period of 1996 and 1997.



                                                                   CASH DIVIDENDS
                                   HIGH              LOW              DECLARED
                                                           
1996

1st Quarter                       76 1/4           60 1/8              $   .42
2nd Quarter                       69 1/4           59 3/4                  .42
3rd Quarter                       62 3/8           50 3/4                  .44
4th Quarter                       58 1/2           52                      .44

1997

1st Quarter                       57               53 1/2              $   .44
2nd Quarter                       64 1/2           50 3/4                  .44
3rd Quarter                       64               57 3/8                  .44
4th Quarter                       65 3/8           56 1/4                  .44


- ----------

As of January 31, 1998 there were 78,445,546 shares of the Company's Common
Stock issued and outstanding, which shares were held by approximately 86,700
shareowners of record. These shares include 184,557 shares held by the Company's
charitable foundation. The Company has declared a cash dividend of $0.44 per
share during the first quarter of 1998, and currently anticipates continuing to
pay quarterly cash dividends. Quarterly dividends on Common Stock, if declared
by the Company's Board of Directors, are usually paid on or about the first
business day of the month following the end of each quarter. The payment of
dividends is a business decision to be made by the Board of Directors from time
to time based on the Company's earnings, financial position and prospects, and
such other considerations as the Board considers relevant. Accordingly, the
Company's dividend policy may change at any time.

The Company did not sell any equity securities during the fourth quarter of 1997
in transactions not registered under the Securities Act of 1933. For information
concerning issuance of shares, a warrant to purchase shares, a warrant to 
purchase shares, and option grants in 1997 under compensation and benefit 
plans and to the Company's charitable foundation, see Part II--Item 
8--Financial Statements and Supplementary Data -- Notes 7 and 8 to 
Consolidated Financial Statements.


                                       18


   19


ITEM 6.      SELECTED FINANCIAL DATA



(DOLLARS IN MILLIONS, EXCEPT PER SHARE AMOUNTS)            1997(1)   1996      1995     1994       1993(2)
                                                                                      
SUMMARY OF OPERATING DATA

Sales                                                   $  4,678  $  4,782  $  5,040  $  4,329  $  3,903
Operating earnings                                           506       663       964       636       451
Earnings from continuing operations
  before income taxes and cumulative
  effect of changes in accounting principle                  446       607       899       550       439
Earnings from continuing operations                          286       380       559       336       267
Discontinued operations, net of taxes                          -         -         -         -       (20)
Cumulative effect of changes
  in accounting principle, net of taxes                        -         -         -         -      (456)
Net earnings (loss)                                          286       380       559       336      (209)
Basic earnings per share(3)                                 3.66      4.84      6.84      4.06      2.47
Diluted earnings per share(3)                               3.63      4.79      6.78      4.04      2.46

STATEMENT OF FINANCIAL POSITION DATA


Current assets                                          $  1,490  $  1,345  $  1,487  $  1,248  $  1,057
Properties at cost                                         8,104     7,530     6,791     6,389     6,390
Accumulated depreciation                                   4,223     4,010     3,742     3,483     3,331
Total assets                                               5,778     5,266     4,872     4,395     4,341
Current liabilities                                          954       787       873       793       462
Long-term borrowings                                       1,714     1,523     1,217     1,195     1,801
Total liabilities                                          4,025     3,627     3,344     3,100     3,280
Total shareowners' equity                                  1,753     1,639     1,528     1,295     1,061
Dividends declared per common share                         1.76      1.72      1.64      1.60         -


- ------------

(1) Operating data for 1997 includes the effect of a $62 million ($40 million
after tax) charge for partial settlement/curtailment of pension and other
postemployment benefit liabilities. See Note 14 to Consolidated Financial
Statements. 

(2) The summary of operating data for 1993 presents the historical combined
results of the Company as the wholly owned worldwide chemical business of Kodak
before the spin-off at midnight December 31, 1993 as if it had operated as an
independent stand-alone entity. Earnings per share for 1993 are presented on a
pro forma basis and are based on pro forma earnings from continuing operations
of $204 million. Historical earnings per share data for 1993 is not presented
because the Company was not a publicly held company before the spin-off and such
data is not meaningful because of the significant change in capitalization as a
result of the spin-off.

(3) Earnings per share for prior years have been restated to conform to
requirements of the new accounting standard effective for periods ending after
December 15, 1997.


                                       19



   20


ITEM 7.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
         OF OPERATIONS

This Management's Discussion and Analysis of Financial Condition and Results of
Operations should be read in conjunction with the Company's consolidated
financial statements included elsewhere in this report. All references to
earnings per share contained in this report are basic earnings per share unless
otherwise noted.

MAJOR FACTORS AFFECTING EARNINGS
1997 COMPARED WITH 1996

     Lower selling prices for the Company's core plastics 
     Overall increased sales volumes 
     Lower purchased raw materials costs 
     Lower variable-incentive compensation 
     Charge resulting from partial settlement/curtailment of
        pension and other postemployment benefit liabilities

RESULTS OF OPERATIONS

EARNINGS



(Dollars in millions, except per share amounts)          1997       1996      CHANGE        1995
                                                                                  
Operating earnings                                     $   506    $   663        (24)%    $   964
Net earnings                                               286        380        (25)         559
Earnings per share (1)
    --Basic                                               3.66       4.84        (24)        6.84
    --Diluted                                             3.63       4.79        (24)        6.78


(1) Earnings per share for prior years have been restated to conform to
requirements of the new accounting standard effective for periods ending after
December 15, 1997.



CHANGES IN EARNINGS PER SHARE                            1997       1996      CHANGE
                                                                         
Earnings per share                                     $3.66      $4.84      $ (1.18)
                                                                             =======
Operations
  Selling price                                                              $ (2.18)
  Volume and mix                                                                 .20
  Raw materials, energy, and supplies                                           1.14
  Variable-incentive pay                                                         .37
Early retirement charge (1)                                                     (.51)
Other                                                                           (.27)
                                                                             -------
    Change from operations                                                     (1.25)
Other
  Interest expense, net                                                         (.16)
  Other income/charges                                                           .12
  Effective tax rate change                                                      .09
  Fewer shares outstanding                                                       .02
                                                                             -------
     Total change                                                             $(1.18)
                                                                              ======


(1) Charge resulting from partial settlement/curtailment of pension and other
postemployment benefit liabilities. See Note 14 to Consolidated Financial
Statements.


                                       20


   21


1997 COMPARED WITH 1996

The Company's 1997 net earnings reflect returns of 17% on equity and 10% on
capital. Sales volumes improved 6% overall due to good demand and new capacity.
However, earnings reflect the significant negative impact of lower EASTAPAK
polymers prices which resulted from excess industry capacity, and substantially
lower acetate tow volume caused by excess industry capacity and customer
inventory reductions, mainly in China. Lower costs were experienced for major
raw materials including paraxylene, purified terephthalic acid ("PTA"), and
propane feedstock. Productivity gains realized from the Company's Advantaged
Cost 2000 program and a gain from damages awarded for patent infringement
positively impacted net earnings. Operating earnings for 1997 reflect a $62
million ($40 million after tax) charge for partial settlement/curtailment of
pension and other postemployment benefit liabilities arising from the retirement
of approximately 1,700 employees. The large number of retirements was not the
result of special payments or incentives. Preproduction costs related to
start-up of new manufacturing facilities had a moderately negative effect on
earnings. The Company's financial results were not materially affected by the
Asian financial crisis in 1997.

SUMMARY BY INDUSTRY SEGMENT

SPECIALTY AND PERFORMANCE SEGMENT



(Dollars in millions)                                    1997       1996      CHANGE        1995
                                                                                
Sales                                                  $ 2,607    $ 2,657        (2)%     $ 2,647
Operating earnings                                         416(1)     519       (20)          433


(1) Specialty and Performance segment operating earnings for 1997 reflect an
allocation of $34 million of the $62 million charge for partial
settlement/curtailment of pension and other postemployment benefit liabilities.
See Note 14 to Consolidated Financial Statements.

1997 COMPARED WITH 1996

The effect of strong volume improvement for specialty plastics and moderately
higher volume for fine chemicals, coatings, inks, and resins products was offset
by overall lower selling prices, a shift in the mix of products sold, and
declines in unit volumes for performance chemicals and fibers. Improved volumes
for plastic esters were driven by good demand for auto coatings, particularly in
developing international regions. Increased sales volumes for specialty
plastics, including TENITE cellulosics and SPECTAR copolymer, reflected new
customer applications and regional growth. Performance chemicals results
reflected lower unit volumes due to divestiture of several product lines in
1996. Demand for acetate tow declined due to new industry capacity and customer
reductions in inventories, mainly in China. The primary factors affecting
operating earnings were significantly lower volumes for acetate tow, overall
lower selling prices, unfavorable foreign currency effects, and the effect of
the early retirement charge, partially offset by lower raw materials costs,
lower variable-incentive pay, and productivity gains.


CORE PLASTICS SEGMENT


(Dollars in millions)                                    1997           1996              CHANGE        1995
                                                                                            
Sales                                                  $ 1,338          $ 1,409              (5)%      $1,685
Operating earnings (loss)                                  (56) (1)          (1)              -           347


(1) Core Plastics segment operating loss for 1997 reflects an allocation of $18
million of the $62 million charge for partial settlement/curtailment of pension
and other postemployment benefit liabilities. See Note 14 to Consolidated
Financial Statements.

                                       21

   22


1997 COMPARED WITH 1996

The decline in container plastics selling prices, which began in 1996 as a
result of industry overcapacity, moderated somewhat by the end of 1997 as prices
showed some recovery and stabilization. Volumes for container plastics showed
significant improvement, primarily as a result of new capacities in Spain and
Mexico and continued strong demand. Lower volumes for flexible plastics
reflected limited availability of ethylene supply prior to the midyear
completion of a new ethylene pipeline. Improved selling prices for flexible
plastics resulted from strong market demand. Operating earnings declined
primarily due to substantially lower selling prices for EASTAPAK polymers,
start-up costs for new manufacturing sites, unfavorable currency effects, and
the effect of the early retirement charge, partially offset by improved selling
prices for flexible plastics, an increase in overall unit volumes, lower raw
materials costs, lower variable-incentive pay, and productivity improvements.


CHEMICAL INTERMEDIATES SEGMENT



(Dollars in millions)                                    1997             1996      CHANGE        1995
                                                                                        
Sales                                                  $   733          $   716       2%        $   708
Operating earnings                                         146(1)           145       1             184



(1) Chemical Intermediates segment operating earnings for 1997 reflect an
allocation of $10 million of the $62 million charge for partial
settlement/curtailment of pension and other postemployment benefit liabilities.
See Note 14 to Consolidated Financial Statements.


1997 COMPARED WITH 1996

Sales in the Chemical Intermediates segment were slightly higher than 1996, with
increased sales volume partially offset by overall lower selling prices and
unfavorable currency exchange rates. Operating earnings reflect lower raw
materials costs and lower variable-incentive pay, offset partially by overall
lower selling prices, unfavorable currency exchange rates, and the effect of the
early retirement charge.

(For supplemental analysis of Specialty and Performance, Core Plastics, and
Chemical Intermediates segment results, see Exhibit 99.01 to this Form 10-K).

SUMMARY BY CUSTOMER LOCATION

SALES BY REGION



(Dollars in millions)                                    1997       1996      CHANGE        1995
                                                                              
United States and Canada                               $ 3,051    $ 3,183         (4)%    $ 3,390
Europe, Middle East, and Africa                            780        745          5          825
Asia Pacific                                               506        548         (8)         557
Latin America                                              341        306         11          268
                                                       -------    -------                 -------

Total                                                  $ 4,678     $4,782                 $ 5,040
                                                       =======     ======                 =======


1997 COMPARED WITH 1996

Sales in the United States for 1997 were $2.875 billion, down 4% from 1996 sales
of $2.990 billion. Decreased sales were attributable to lower selling prices,
primarily for EASTAPAK polymers.


                                       22



   23


Sales outside the United States in 1997 were relatively unchanged from 1996 and
were 39% of total sales compared to 37% of total sales in 1996. Higher sales
volume driven by new capacities in Mexico and Spain was mostly offset by
unfavorable currency effects and overall lower selling prices. Decreased sales
in Asia Pacific reflect a decline in sales of acetate tow.

With a substantial portion of 1997 sales to customers outside the United States
and approximately 10% of its products manufactured outside the United States,
Eastman is subject to the risks associated with operating in international
markets. To mitigate its exchange rate risks, the Company frequently seeks to
negotiate payment terms in U.S. dollars. In addition, where it deems such
actions advisable, the Company engages in foreign currency hedging transactions
and requires letters of credit and prepayment for shipments where its assessment
of individual customer and country risks indicates their use is appropriate.
Foreign currency hedging transactions mitigated the impact of foreign currency
transaction and remeasurement losses. However, the change in exchange rates when
compared to 1996 negatively impacted net earnings by approximately $35 million.
See Note 10 to Consolidated Financial Statements and Market Risk discussion.


SUMMARY OF CONSOLIDATED RESULTS



(Dollars in millions)                                    1997       1996      CHANGE        1995
                                                                                  
SALES                                                  $4,678      $4,782      (2)%        $5,040


Sales volume in 1997 improved 6% overall, but generally lower selling prices, a
shift in mix of products sold, and unfavorable currency effects resulted in
sales declining 2%.



(Dollars in millions)                                    1997       1996      CHANGE        1995
                                                                                  
GROSS PROFIT                                             $1,096      $1,179   (7)%         $1,504
   As a percentage of sales                                23.4%       24.7%                 29.8%



Gross profit decline was principally attributable to lower selling prices,
partially offset by overall lower purchased raw materials costs, lower
variable-incentive compensation, and productivity gains.



(Dollars in millions)                                    1997       1996      CHANGE        1995
                                                                                   
SELLING AND GENERAL ADMINISTRATIVE EXPENSES              $   337     $  332       2%        $   364
   As a percentage of sales                                  7.2%       6.9%                    7.2%


Selling and general administrative expenses were up slightly in 1997 due to a
variety of general business activities relating to new business formations and
globalization strategies, increased advertising and outside professional
services, and higher compensation costs, partially offset by a reduction in
labor hours and lower variable-incentive costs.



(Dollars in millions)                                    1997       1996      CHANGE        1995
                                                                                   
RESEARCH AND DEVELOPMENT COSTS                           $   191    $   184       4%        $   176
   As a percentage of sales                                  4.1%       3.8%                    3.5%


Increased research and development costs resulted from increased level of
activity, partially offset by lower variable-incentive costs.



(Dollars in millions)                                    1997       1996      CHANGE        1995
                                                                              
INTEREST COSTS                                         $   128    $    95                 $    88
LESS CAPITALIZED INTEREST                                   41         28                       9
                                                       -------    -------                 -------
NET INTEREST EXPENSE                                   $    87    $    67         30%     $    79
                                                       =======    =======                 =======



                                       23


   24


Interest costs increased due to an increase in borrowings and higher overall
effective interest rates. The increase in capitalized interest was directly
related to the major capital investment program which peaked in 1997.



(Dollars in millions)                                    1997       1996      CHANGE        1995
                                                                                 
OTHER INCOME, NET                                        $ 27       $ 11       >100%         $ 14


In 1997 the Company recognized increased income from Genencor International, a
joint venture that develops, manufactures, and markets industrial enzymes and
other fine and specialty chemicals. Also in 1997 the Company realized a gain
from an award of damages for patent infringement. In 1996 the Company recognized
a gain from the sale of the Company's food emulsifier business. All years
include royalty and interest income, the effect of foreign currency transactions
and translation, and income (loss) from joint ventures and equity investments.



(Dollars in millions)                                    1997       1996      CHANGE        1995
                                                                                 
PROVISION FOR INCOME TAXES                               $  160     $  227     (30)%        $  340
   Effective tax rate                                      35.8%      37.4%                   37.8%


The reduction in effective tax rate for 1997 resulted primarily from increased
tax benefits attributable to export sales and the recognition of tax benefits
attributable to foreign operations.

1996 COMPARED WITH 1995

Eastman posted sales in 1996 of $4.782 billion, down 5% compared with 1995.
Sales decreased 7% because of lower selling prices, offset 2% because of volume
gains. The Company had net earnings of $380 million in 1996, compared with $559
million for 1995 -- a 32% decrease. The factors contributing to the earnings
decline were lower selling prices for the Company's core plastics, EASTAPAK
polymers and polyethylene, preproduction and start-up costs at new EASTAPAK
polymers plants, and higher labor rates. Currency fluctuations had a minor
negative effect on earnings in 1996. Positive impacts on overall earnings
included higher overall sales volumes, lower variable-incentive compensation,
and lower costs for paraxylene, certain other raw materials, and energy,
partially offset by higher propane costs.

The Specialty and Performance segment reported sales of $2.657 billion for 1996,
essentially level with 1995. The operating earnings for 1996 were $519 million,
up 20% from 1995. This increase was primarily a result of lower operating costs
reflecting overall lower raw materials costs, divestiture and discontinuance of
certain businesses and product lines, favorable product mix changes, and lower
variable-incentive compensation. Improved pricing, particularly for acetate tow
and acetate yarn, also contributed to the increase in earnings. Sales of
coatings, inks, and resins products increased because of higher volumes,
partially offset by decreased prices. Fibers sales increased primarily because
of price increases at the beginning of 1996 and slight volume gains. Fine
chemicals products sales were down primarily because of lower volumes. Specialty
plastics products sales were essentially level with 1995, with volume increases
offset by price decreases. Sales of performance chemicals products decreased
because of lower volumes, partially offset by higher prices, and as a result of
the divestiture and discontinuance of certain businesses and product lines in
late 1995 and early 1996.

The Core Plastics segment reported sales of $1.409 billion for 1996, down 16%
from 1995. The sales decrease in the Core Plastics segment was attributed
primarily to lower EASTAPAK polymers selling prices, partially offset by
increased volumes. The segment operating loss of $1 million was attributed
primarily to lower EASTAPAK polymers and polyethylene selling prices. Other
factors contributing to the overall decrease in segment operating earnings were
increased preproduction and start-up costs for new EASTAPAK polymers
manufacturing facilities and increased propane costs, which impacted primarily
polyethylene and to a lesser extent EASTAPAK polymers.


                                       24


   25


The Chemical Intermediates segment reported sales of $716 million for 1996, up
1% from 1995. The slight increase in sales was attributed primarily to higher
volumes, partially offset by lower selling prices for certain industrial
intermediates. Chemical Intermediates segment operating earnings for 1996 were
$145 million, down 21% from 1995. Decreased operating earnings were attributed
primarily to lower selling prices for certain industrial intermediates products,
particularly n-butyraldehyde products and their derivatives, and higher propane
feedstock costs.

Sales in the United States in 1996 were $2.990 billion, down 6% compared with
1995 sales of $3.168 billion. Decreased sales were attributed to lower selling
prices, partially offset by modest volume gains. Sales to customers outside the
United States in 1996 were down 4% compared with 1995 and were 37% of total
sales, same as 1995. Decreased sales in Europe, Middle East, and Africa were
primarily attributed to lower EASTAPAK polymers selling prices, partially offset
by higher volumes. Increased sales in Latin America resulted primarily from
higher EASTAPAK polymers volumes, partially offset by lower selling prices.


                                       25



   26


LIQUIDITY, CAPITAL RESOURCES, AND OTHER FINANCIAL DATA



FINANCIAL INDICATORS                                             1997          1996         1995
                                                                                    
Ratio of earnings to fixed charges                                3.7x         6.1x          9.7x
Current ratio (1)                                                 1.6x         1.7x          1.7x
Percent of long-term borrowings to total capital (1)               49%          48%           44%
Percent of floating-rate borrowings to total borrowings (1)        12%          21%            2%

- -------------
(1)  At end of year.



CASH FLOW
(Dollars in millions)                                            1997         1996          1995
                                                                                       
Net cash provided by (used in)
  Operating activities                                           $    698     $    746      $   838
  Investing activities                                               (745)        (809)        (524)
  Financing activities                                                 52          (13)        (304)
                                                                 --------     --------      -------
Net change in cash and cash equivalents                          $      5     $    (76)     $    10
                                                                 ========     ========      =======
Cash and cash equivalents at end of period                       $     29     $     24      $   100
                                                                 ========     ========      =======


Cash provided by operations has declined over the periods presented mainly due
to lower net earnings reflecting business conditions previously discussed. Cash
used in investing activities peaked in 1996 due to significant global expansion
activities underway at that time. Cash related to financing activities reflects
significant treasury stock purchases in 1995 and 1996, proceeds received in 1997
from a $300 million issuance of 7.60% debentures due February 1, 2027, and the
payment of dividends in all years presented. For additional analysis, see also
the Consolidated Statements of Cash Flows.

CAPITAL EXPENDITURES AND OTHER COMMITMENTS

Eastman anticipates total capital expenditures in 1998 will be between $550
million and $600 million and depreciation expense is expected to be
approximately $350 million. Long-term commitments related to capital
expenditures are not material. The Company had various purchase commitments at
the end of 1997 for materials, supplies, and energy incident to the ordinary
conduct of business. These commitments total approximately $800 million. Eastman
has other long-term commitments relating to joint venture agreements as
described in Note 4 to Consolidated Financial Statements.

LIQUIDITY

Eastman has access to an $800 million revolving credit facility (the "Credit
Facility") expiring in December 2000. Although the Company does not have any
amounts outstanding under the Credit Facility, any such borrowings would be
subject to interest at varying spreads above quoted market rates, principally
LIBOR. The Credit Facility also requires a facility fee on the total commitment
that varies based on Eastman's credit rating. The annual rate for such fee was
0.075% in 1997, 1996, and 1995. The Credit Facility contains a number of
covenants and events of default, including the maintenance of certain financial
ratios. Eastman was in compliance with all such covenants for all periods.

Eastman utilizes commercial paper, generally with maturities of 90 days or less,
to meet its liquidity needs. The Company's commercial paper, supported by the
Credit Facility, is classified as long-term borrowings because the Company has
the ability and intent to refinance such borrowings long-term. As of December
31, 1997, the Company's commercial paper outstanding balance was $213 million,
at interest rates ranging between 6.10% and 6.90%. At December 31, 1996, a total
of $295 million of commercial paper was outstanding, at interest rates ranging
between 5.50% and 6.15%. In 1997 Eastman issued $300 million of 7.60% debentures
due February 1, 2027, and used the proceeds to repay commercial paper borrowings
outstanding at that time.


                                       26


   27


In 1995 the Company repurchased 3,308,200 shares of common stock at a cost of
$200 million. In February 1996 the Company announced plans to repurchase up to
$400 million of additional common stock. In 1996 the Company acquired 2,486,300
shares at a cost of $161 million under the announced repurchase program, and
during the first quarter 1997 acquired an additional 140,801 shares at a cost of
$8 million. There were no share repurchases during the remainder of the year.
Repurchased shares may be used to meet common stock requirements for
compensation and benefit plans and other corporate purposes.

The partial settlement/curtailment of pension and other postemployment benefit
liabilities which occurred in 1997 will result in funding which the Company
plans to make in 1998.

Existing sources of capital, together with cash flows from operations, are
expected to be sufficient to meet foreseeable cash flow requirements.



DIVIDENDS                                           1997       1996       1995
                                                                  
Cash dividends declared per share                $  1.76    $  1.72    $  1.64


ENVIRONMENTAL

Certain Eastman manufacturing sites generate hazardous and nonhazardous wastes,
of which the treatment, storage, transportation, and disposal are regulated by
various governmental agencies. In connection with the cleanup of various
hazardous waste sites, the Company, along with many other entities, has been
designated a potentially responsible party ("PRP") by the U.S. Environmental
Protection Agency under the Comprehensive Environmental Response, Compensation
and Liability Act, which potentially subjects PRPs to joint and several
liability for such cleanup costs. In addition, the Company will be required to
incur costs for environmental remediation and closure/postclosure under the
federal Resource Conservation and Recovery Act. Because of expected sharing of
costs, the availability of legal defenses, and the Company's preliminary
assessment of actions that may be required, the Company does not believe its
liability for these environmental matters, individually or in the aggregate,
will be material to Eastman's consolidated financial position, results of
operations, or competitive position.

Eastman's environmental protection and improvement cash expenditures were
approximately $220 million in 1997, $175 million in 1996, and $150 million in
1995, including investments in construction, operations, and development. The
Company does not expect future environmental capital expenditures arising from
requirements of recently promulgated environmental laws and regulations to
materially increase the Company's planned level of capital expenditures for
environmental control facilities.

INFLATION

In recent years inflation has not had a material adverse impact on Eastman's
costs, primarily because of price competition among suppliers of raw materials.
However, changes in raw materials prices, particularly petroleum derivatives,
could have a significant impact on costs, which the Company may or may not be
able to reflect fully in its pricing structure.

MARKET RISK

The Company is exposed to changes in financial market conditions in the normal
course of its business due to its use of certain financial instruments as well
as transacting in various foreign currencies and funding of foreign operations.
To mitigate the Company's exposure to these market risks, Eastman has
established policies, procedures, and internal processes governing its
management of financial market risks and the use of financial instruments to
manage its exposure to such risks.

The Company is exposed to changes in interest rates primarily as a result of its
borrowing activities, which include short-term commercial paper and long-term
borrowings used to maintain liquidity and fund its business operations. The
Company continues to utilize U.S. dollar-denominated commercial paper to fund
seasonal working capital requirements. The nature and amount of the Company's
long-term and short-term debt may vary as a result of future business
requirements, market conditions, and other factors.


                                       27

   28


The Company's operating cash flows denominated in foreign currencies are exposed
to changes in foreign exchange rates. The Company continually evaluates its
foreign currency exposure based on current market conditions and the locations
in which the Company conducts business. In order to mitigate the effect of
foreign currency risk, the Company enters into forward exchange contracts to
hedge certain firm commitments denominated in foreign currencies and currency
options to hedge probable anticipated but not yet committed export sales and
purchase transactions expected within no more than 5 years and denominated in
foreign currencies. The gains and losses on these contracts offset changes in
the value of related exposures. It is the Company's policy to enter into foreign
currency transactions only to the extent considered necessary to meet its
objectives as stated above. The Company does not enter into foreign currency
transactions for speculative purposes.

The Company determines its market risk utilizing sensitivity analysis, which
measures the potential losses in fair value resulting from one or more selected
hypothetical changes in interest rates and/or foreign currency exchange rates.
The market risk associated with the fair value of interest-rate-sensitive
instruments assuming an instantaneous parallel shift in interest rates of 10% is
approximately $100 million and an additional $10 million for each one percentage
point change in interest rates thereafter. This exposure is primarily related to
long-term debt with fixed interest rates. The market risk associated with
foreign currency-sensitive instruments utilizing a modified Black-Scholes option
pricing model and a 10% adverse move in the U.S. dollar relative to each foreign
currency hedged by the Company is approximately $70 million and an additional $6
million for a one percentage point change in foreign currency exchange rates.
Further adverse movements in foreign currencies would create losses in fair
value; however, such losses would not be linear to that disclosed above. This
exposure, which is primarily related to foreign currency options purchased by
the Company to manage fluctuations in foreign currencies, is limited to the
dollar value of option premiums payable by the Company for the related financial
instruments. Furthermore, since the Company utilizes currency-sensitive
derivative instruments for hedging anticipated foreign currency transactions, a
loss in fair value for those instruments is generally offset by increases in the
value of the underlying anticipated transactions.

YEAR 2000 ISSUE

The year 2000 issue is the result of computer programs written using two digits
rather than four to define the applicable year. Without corrective action,
programs with time-sensitive software could potentially recognize a date ending
in "00" as the year 1900 rather than the year 2000, causing many computer
applications to fail or create erroneous results.

Assessment and remediation of the Company's business computer systems,
manufacturing control systems, and other embedded-chip devices for compliance
with the year 2000 is underway or in some cases completed. As a result of
modifications or upgrades planned or already completed, the Company believes
that the year 2000 issue will not pose significant problems for the Company's
business, operations, or operating systems. The Company expects that any
additional modifications or upgrades of software or hardware required for year
2000 compatibility will be accomplished using existing resources and will not
have a material impact on the Company's financial position or results of
operations in future periods.

The Company has identified and is contacting customers, suppliers, and other
critical business partners to determine if entities with which the Company
transacts business have an effective plan in place to address the year 2000
issue. Contingency plans will be developed as needed.

HOLSTON DEFENSE CORPORATION

Holston Defense Corporation, a wholly owned subsidiary of the Company, has
managed the government-owned Holston Army Ammunition Plant in Kingsport,
Tennessee since 1942 under contract with the Department of Army. The current
contract expires December 31, 1998. Holston Defense Corporation has been
notified that it is not a participant in the bidding process for the contract
period beginning after December 31, 1998. In the event that Holston Defense
Corporation's management of the ammunition plant is terminated, payments to
Holston Defense Corporation's employees, additional funding of pension and other
postretirement benefits, and other termination costs could result. The Company
expects that substantially all of these costs and payments would be ultimately
reimbursed by the Department of Army, although delays in reimbursement may
require the Company to advance funds to pay such costs. Any unreimbursable
amounts charged to future earnings should not have a material adverse effect on
the Company, although earnings in a particular quarter could be negatively
impacted. See Note 17 to Consolidated Financial Statements.


                                       28


   29


RECENTLY ISSUED ACCOUNTING STANDARDS

In June 1997 the FASB issued two new Statements: SFAS No. 130, "Reporting
Comprehensive Income," and SFAS No. 131, "Disclosures about Segments of an
Enterprise and Related Information." SFAS No. 130 requires all items recognized
as components of other comprehensive income to be reported in the financial
statements. SFAS No. 131 requires enterprises to report selected information
about operating segments and related disclosures about products and services,
geographic areas, and major customers. The Company will provide additional
reporting as required by the new standards beginning in 1998. The Company
believes that no significant changes to current segment reporting will be
required by the new standard.


OUTLOOK

In 1998 the Company expects higher sales compared to 1997, driven by good demand
and strong volume growth for products in all three segments as a result of new
applications and new production capacity. However, EASTAPAK polymers and
ethylene and propylene derivatives such as oxo chemicals and polyethylene may
face price and margin pressure as a result of additional industry capacity.
Significant SPECTAR copolymer volume growth is expected due to strong demand and
added production capacity in Malaysia. Volume growth is expected for the
coatings line, driven by good demand for auto coatings and architectural
coatings. Acetate tow volume is expected to stabilize as new industry capacity
is absorbed and customer inventory reductions are completed, but price and
margin pressure will result from the new capacities. Modest growth in sales
revenue is expected for fine chemicals based on increased volumes of
pharmaceutical and agrochemical intermediates and the impact of new
Epoxybutene-based derivatives. Strong revenue growth is expected for performance
chemicals due to new capacities for EASTOTAC resins and EASTOBRITE optical
brighteners. Within the Core Plastics segment, demand for EASTAPAK polymers is
expected to continue to grow as new applications are developed. Increased
revenues and operating earnings are expected for container plastics products,
driven by additional available capacity, reduced costs, and stable pricing.
Recently introduced polyethylene performance polymers, MXSTEN and TENITE HIFOR,
are expected to provide more profitable and less cyclical niche markets as they
gain market acceptance. Within the Chemical Intermediates segment, a recently
completed U.S. oxo plant expansion is expected to produce continued volume
gains. The Company does not expect to have significant credit or business
exposure relating to the Asian financial crisis.

The Company is prepared to take the necessary steps through its capital spending
program and its Advantaged Cost 2000 initiative to maintain the financial
flexibility necessary to realize its full potential to create value. The 1998
target for the Company's Advantaged Cost 2000 initiative is $100 million in
labor and material productivity gains. In 1998 the Company expects a 20%
reduction in capital spending, and depreciation expense is expected to be
approximately $350 million.

The above-stated expectations, other forward-looking statements in this report,
and other statements of the Company relating to matters such as cost reduction
targets; planned capacity increases and capital spending; the year 2000 issue;
the Asian financial crisis; expected tax rates and depreciation; and supply and
demand, unit volume, price, margin, and sales and earnings expectations and
strategies for individual products, businesses, and segments, as well as for the
whole of the Company, are based upon certain underlying assumptions. These
assumptions are in turn based upon internal estimates and analyses of current
market conditions and trends, management plans and strategies, economic
conditions, and other factors and are subject to risks and uncertainties
inherent in projecting future conditions and results.

The forward-looking statements in this Management's Discussion and Analysis are
based upon the following assumptions and those mentioned in the context of the
specific statements: relatively stable economic business conditions in North
America, improving business conditions in Europe, and continued growth in Latin
America, supporting continued good overall demand for the Company's products; no
significant impact on results of operations due to the Asian financial crisis;
no significant decline in overall selling prices, except for fibers; continued
demand growth worldwide for EASTAPAK polymers; continued capacity additions
within the PET industry worldwide; capacity additions within the ethylene
industry worldwide; realization of recent


                                       29


   30


EASTAPAK polymers price increases; stabilization of acetate tow demand and
volume; relatively stable prices for and availability of key purchased raw
materials; good market reception of new polyethylene products; availability of
announced manufacturing capacity increases; and labor and material productivity
gains sufficient to meet targeted cost structure reductions. Actual results
could differ materially from current expectations if one or more of these
assumptions prove to be inaccurate or are unrealized.





- ------------------------------------
EASTAPAK, SPECTAR, MXSTEN, TENITE and TENITE HIFOR are trademarks of Eastman
Chemical Company.


                                       30



   31


ITEM 8.  FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA



ITEM                                                                       PAGE
                                                                       
Management's responsibility for financial statements                         32

Report of independent accountants                                            33

Consolidated statements of earnings and retained earnings                    34

Consolidated statements of financial position                                35

Consolidated statements of cash flows                                        36

Notes to consolidated financial statements                                37-59



                                       31

   32


MANAGEMENT'S RESPONSIBILITY FOR FINANCIAL STATEMENTS

Management is responsible for the preparation and integrity of the accompanying
consolidated financial statements of Eastman Chemical Company and subsidiaries
appearing on pages 34 through 59. Eastman has prepared these consolidated
financial statements in accordance with generally accepted accounting
principles, and the statements of necessity include some amounts that are based
on management's best estimates and judgments.

Eastman's accounting systems include extensive internal controls designed to
provide reasonable assurance of the reliability of its financial records and the
proper safeguarding and use of its assets. Such controls are based on
established policies and procedures, are implemented by trained, skilled
personnel with an appropriate segregation of duties, and are monitored through a
comprehensive internal audit program. The Company's policies and procedures
prescribe that the Company and all employees are to maintain the highest ethical
standards and that its business practices throughout the world are to be
conducted in a manner that is above reproach.

The consolidated financial statements have been audited by Price Waterhouse LLP,
independent accountants, who were responsible for conducting their audits in
accordance with generally accepted auditing standards. Their report is included
herein.

The Board of Directors exercises its responsibility for these financial
statements through its Audit Committee, which consists entirely of nonmanagement
Board members. The independent accountants and internal auditors have full and
free access to the Audit Committee. The Audit Committee meets periodically with
Price Waterhouse LLP and Eastman's director of internal auditing, both privately
and with management present, to discuss accounting, auditing, policies and
procedures, internal controls, and financial reporting matters.



/s/ Earnest W. Deavenport, Jr.                /s/ H. Virgil Stephens
- ------------------------------                ---------------------------
Earnest W. Deavenport, Jr.                    H. Virgil Stephens
Chairman of the Board and                     Senior Vice President and
   Chief Executive Officer                       Chief Financial Officer

January 27, 1998


                                       32


   33


REPORT OF INDEPENDENT ACCOUNTANTS


To the Board of Directors and Shareowners of
Eastman Chemical Company

In our opinion, the accompanying consolidated financial statements listed in the
index appearing under Item 14(a)(1) on page 62 present fairly, in all material
respects, the financial position of Eastman Chemical Company and subsidiaries at
December 31, 1997 and 1996, and the results of their operations and their cash
flows for each of the three years in the period ended December 31, 1997, in
conformity with generally accepted accounting principles. These financial
statements are the responsibility of the Company's management; our
responsibility is to express an opinion on these financial statements based on
our audits. We conducted our audits of these statements in accordance with
generally accepted auditing standards which require that we plan and perform the
audit to obtain reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial statements,
assessing the accounting principles used and significant estimates made by
management, and evaluating the overall financial statement presentation. We
believe that our audits provide a reasonable basis for the opinion expressed
above.





/s/ Price Waterhouse LLP
- -------------------------------
PRICE WATERHOUSE LLP
New York, New York
January 27, 1998


                                       33


   34


                   EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

           CONSOLIDATED STATEMENTS OF EARNINGS AND RETAINED EARNINGS
                (DOLLARS IN MILLIONS, EXCEPT PER SHARE AMOUNTS)



                                                   1997           1996           1995
                                                                            
Sales                                            $ 4,678        $ 4,782        $ 5,040  
Cost of sales                                      3,582          3,603          3,536  
                                                 -------        -------        -------  
Gross profit                                       1,096          1,179          1,504  
                                                                                        
Selling and general administrative expenses          337            332            364  
Research and development costs                       191            184            176  
Early retirement charge                               62             --             --  
                                                 -------        -------        -------  
Operating earnings                                   506            663            964  
                                                                                        
Interest expense, net                                 87             67             79  
Other income, net                                     27             11             14  
                                                 -------        -------        -------  
Earnings before income taxes                         446            607            899  
                                                                                        
Provision for income taxes                           160            227            340  
                                                 -------        -------        -------  
                                                                                        
Net earnings                                     $   286        $   380        $   559  
                                                 =======        =======        =======  
                                                                                        
Basic earnings per share                         $  3.66        $  4.84        $  6.84  
                                                 =======        =======        =======  
Diluted earnings per share                       $  3.63        $  4.79        $  6.78  
                                                 =======        =======        =======  
                                                                                        
Retained earnings at beginning of year           $ 1,929        $ 1,684        $ 1,258  
Net earnings                                         286            380            559  
Cash dividends declared                             (137)          (135)          (133) 
                                                 -------        -------        -------  
                                                                                        
Retained earnings at end of year                 $ 2,078        $ 1,929        $ 1,684  
                                                 =======        =======        =======  



The accompanying notes are an integral part of these financial statements.


                                       34

   35


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                  CONSOLIDATED STATEMENTS OF FINANCIAL POSITION
                              (DOLLARS IN MILLIONS)



                                                                                 DECEMBER 31,
                                                                               1997         1996
                                                                                        
ASSETS
Current assets
  Cash and cash equivalents                                                $      29    $      24
  Receivables                                                                    793          744
  Inventories                                                                    511          465
  Other current assets                                                           157          112
                                                                           ---------    ---------
    Total current assets                                                       1,490        1,345
                                                                           ---------    ---------

Properties
  Properties and equipment at cost                                             8,104        7,530
  Less:  Accumulated depreciation                                              4,223        4,010
                                                                           ---------    ---------
    Net properties                                                             3,881        3,520
                                                                           ---------    ---------

Other noncurrent assets                                                          407          401
                                                                           ---------    ---------

    Total assets                                                           $   5,778    $   5,266
                                                                           =========    =========

LIABILITIES AND SHAREOWNERS' EQUITY
Current liabilities
  Payables and other current liabilities                                   $     954    $     787
                                                                            --------     --------
    Total current liabilities                                                    954          787

Long-term borrowings                                                           1,714        1,523
Deferred income tax credits                                                      397          348
Postemployment obligations                                                       724          722
Other long-term liabilities                                                      236          247
                                                                           ---------    ---------
    Total liabilities                                                          4,025        3,627
                                                                           ---------    ---------

Shareowners' equity
  Common stock ($0.01 par - 350,000,000 shares authorized;
    shares issued -- 84,144,672 and 83,386,459)                                    1            1
  Paid-in capital                                                                 77           37
  Retained earnings                                                            2,078        1,929
  Other                                                                          (37)          31
                                                                           ----------   ---------
                                                                               2,119        1,998

  Less:  Treasury stock at cost (5,889,311 and 5,766,528 shares)                 366          359
                                                                           ---------    ---------

    Total shareowners' equity                                                  1,753        1,639
                                                                           ---------    ---------

    Total liabilities and shareowners' equity                              $   5,778    $   5,266
                                                                           =========    =========



The accompanying notes are an integral part of these financial statements.


                                       35


   36


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                              (DOLLARS IN MILLIONS)


                                                                 1997          1996         1995
                                                                                     
Cash flows from operating activities
  Net earnings                                                $     286    $     380    $     559
                                                              ---------    ---------    ---------

  Adjustments to reconcile net earnings to
  net cash provided by operating activities
      Depreciation                                                  327          314          308
      Provision (benefit) for deferred income taxes                   7            8          (11)
      (Increase) decrease in receivables                            (53)          66          (90)
      (Increase) decrease in inventories                            (65)          10         (108)
      Increase (decrease) in employee benefit liabilities
        and incentive pay                                           134          (69)         179
      Increase in liabilities excluding borrowings,
        employee benefit liabilities, and incentive pay              60           31           18
      Other items, net                                                2            6          (17)
                                                              ---------    ---------    ----------
    Total adjustments                                               412          366          279
                                                              ---------    ---------    ---------

    Net cash provided by operating activities                       698          746          838
                                                              ---------    ---------    ---------

Cash flows from investing activities
  Additions to properties and equipment                            (749)        (789)        (446)
  Acquisitions and investments in joint ventures                      -          (26)         (56)
  Proceeds from sales of assets                                      20           43            9
  Capital advances to suppliers                                     (21)         (37)         (39)
  Other items                                                         5            -            8
                                                              ---------    ---------    ---------

    Net cash used in investing activities                          (745)        (809)        (524)
                                                              ----------   ---------    ---------

Cash flows from financing activities
  Proceeds from long-term borrowings                                295            -            -
  Net increase (decrease) in commercial paper borrowings            (82)         273           22
  Repayment of borrowings                                           (22)           -           (2)
  Dividends paid to shareowners                                    (138)        (134)        (133)
  Treasury stock purchases                                           (8)        (161)        (200)
  Other items                                                         7            9            9
                                                              ---------    ---------    ---------

    Net cash provided by (used in) financing activities              52          (13)        (304)
                                                              ---------    ---------    ---------

    Net change in cash and cash equivalents                           5          (76)          10

Cash and cash equivalents at beginning of year                       24          100           90
                                                              ---------    ---------    ---------

Cash and cash equivalents at end of year                      $      29    $      24    $     100
                                                              =========    =========    =========



The accompanying notes are an integral part of these financial statements.


                                       36


   37


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

1.     SIGNIFICANT ACCOUNTING POLICIES

       FINANCIAL STATEMENT PRESENTATION

       The consolidated financial statements of Eastman Chemical Company and
       subsidiaries ("Eastman" or the "Company") are prepared in conformity with
       generally accepted accounting principles and of necessity include some
       amounts that are based upon management estimates and judgments. Future
       actual results could differ from such current estimates. The Consolidated
       Financial Statements include assets, liabilities, revenues, and expenses
       of all wholly owned subsidiaries. Eastman accounts for joint ventures and
       investments in minority-owned companies where it exercises significant
       influence on the equity basis. Intercompany transactions and balances are
       eliminated in consolidation.

       TRANSLATION OF NON-U.S. CURRENCIES

       Eastman uses the local currency as the "functional currency" to translate
       the accounts of all consolidated entities outside the United States where
       cash flows are primarily denominated in local currencies. The effects of
       translating those operations that use the local currency as the
       functional currency are included as a separate component of shareowners'
       equity. The effects of remeasuring those operations where the U.S. dollar
       is used as the functional currency and all transaction gains and losses
       are reflected in current earnings.

       REVENUE RECOGNITION

       Sales are recognized when products are shipped and the earnings process
       is complete. Appropriate accruals for discounts, volume rebates, and
       other allowances are recorded as reductions in sales.

       CASH AND CASH EQUIVALENTS

       Cash and cash equivalents include cash, time deposits, and readily
       marketable securities with original maturities of 3 months or less.

       INVENTORIES

       Inventories are valued at cost, which is not in excess of market. The
       Company determines the cost of most raw materials, work in process, and
       finished goods inventories by the last-in, first-out (LIFO) method. The
       cost of all other inventories, including inventories outside the United
       States, is determined by the first-in, first-out (FIFO) or average cost
       method.

       PROPERTIES

       The Company records properties at cost. Maintenance and repairs are
       charged to earnings; replacements and betterments are capitalized. When
       Eastman retires or otherwise disposes of assets, it removes the cost of
       such assets and related accumulated depreciation from the accounts. The
       Company records any profit or loss on retirement or other disposition in
       earnings.

       DEPRECIATION

       Depreciation expense is calculated based on historical cost and the
       estimated useful lives of the assets (buildings and building equipment 20
       to 50 years; machinery and equipment 3 to 33 years), generally using the
       straight-line method. For U.S. assets acquired before January 1, 1992,
       the Company generally uses accelerated methods to calculate the provision
       for depreciation.


                                       37


   38


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

       IMPAIRED ASSETS

       The Company reviews the carrying values of long-lived assets and
       intangibles for impairment whenever events or changes in circumstances
       indicate that the carrying amount of an asset may not be recoverable.
       Measurement of any impairment would include a comparison of discounted
       estimated future operating cash flows to the net carrying value of the
       related assets.

       DERIVATIVE FINANCIAL INSTRUMENTS

       Derivative financial instruments are used by the Company in the
       management of its foreign currency exposures. The purpose of the
       Company's foreign currency hedging activities is to protect the Company
       from the risk that changes in exchange rates will adversely affect the
       eventual dollar cash flows resulting from such transactions. The Company
       enters into forward exchange contracts to hedge certain firm commitments
       denominated in foreign currencies and currency options to hedge probable
       anticipated but not yet committed export sales and purchase transactions
       expected within no more than 5 years and denominated in foreign
       currencies (principally the German mark, French franc, and Japanese yen).
       The Company's forward and option contracts are accounted for as hedges
       because the derivative instruments are designated and effective as hedges
       and reduce the Company's exposure to foreign currency risks. Gains and
       losses resulting from effective hedges of existing assets, liabilities,
       firm commitments, or anticipated transactions are deferred and recognized
       when the offsetting gains and losses are recognized on the related hedged
       items and are reported as a component of operating earnings. Deferred
       premiums and the related obligation for payment are generally included in
       other noncurrent assets and liabilities, respectively, and are paid in
       the period in which the options are exercised or expire and forward
       exchange contracts mature.

       INVESTMENTS

       The Company includes in other noncurrent assets its investments in joint
       ventures, which are managed as integral parts of the Company's operations
       and accounted for on the equity basis. Eastman carries certain
       investments at negative values, based on its intention to fund its share
       of deficits in such investments, and includes such negative carrying
       values in other long-term liabilities. The Company includes its share of
       earnings and losses of such joint ventures in other income and charges.

       EARNINGS PER SHARE

       Basic earnings per share reflect reported earnings divided by the
       weighted average number of common shares outstanding. Diluted earnings
       per share include the effect of dilutive stock options outstanding during
       the year. Prior earnings per share amounts have been restated to conform
       to requirements of the new accounting standard effective for periods
       ending after December 15, 1997.

       INCOME TAXES

       Deferred income taxes, reflecting the impact of temporary differences
       between the assets and liabilities recognized for financial reporting
       purposes and amounts recognized for tax purposes, are based on tax laws
       currently enacted.

       STOCK-BASED COMPENSATION

       Compensation cost attributable to stock option and similar plans is
       recognized based on the difference, if any, between the quoted market
       price of the stock on the date of grant over the amount the employee is
       required to pay to acquire the stock (intrinsic value method). Such
       amount, if any, is accrued over the related vesting period, as
       appropriate.


                                       38


   39


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

       COMPENSATED ABSENCES

       The Company accrues compensated absences and related benefits as current
       charges to earnings.

       ENVIRONMENTAL COSTS

       The Company accrues environmental costs when it is probable that the
       Company has incurred a liability and the amount can be reasonably
       estimated. Estimated costs associated with closure/postclosure are
       accrued over the facilities' estimated remaining useful lives. Accruals
       for environmental liabilities are included in other long-term liabilities
       at undiscounted amounts and exclude claims for recoveries from insurance
       companies or other third parties. Environmental costs are capitalized if
       they extend the life of the related property, increase its capacity,
       and/or mitigate or prevent future contamination. The cost of operating
       and maintaining environmental control facilities is charged to expense.

       RECLASSIFICATIONS

       The Company has reclassified certain 1996 and 1995 amounts to conform to
       the 1997 presentation.

2.     INVENTORIES



                                                                                 DECEMBER 31,
       (Dollars in millions)                                                   1997         1996
                                                                                        
       At FIFO or average cost (approximates current cost)

           Finished goods                                                  $     436    $     426
           Work in process                                                       140          133
           Raw materials and supplies                                            211          214
                                                                           ---------    ---------
       Total inventories at FIFO or average cost                                 787          773
       Reduction to LIFO value                                                  (276)        (308)
                                                                           ---------    ---------

       Total inventories at LIFO value                                     $     511    $     465
                                                                           =========    =========


       Inventories valued on the LIFO method were approximately 75% of total
       inventories in 1997 and 1996.

3.     PROPERTIES AND ACCUMULATED DEPRECIATION

       PROPERTIES AT COST



       (Dollars in millions)                                     1997          1996         1995
                                                                                     
       Balance at beginning of year                           $   7,530    $   6,791    $   6,389
           Additions                                                749          796          464
           Deductions                                              (175)         (57)         (62)
                                                              ----------   ---------    ---------

       Balance at end of year                                 $   8,104    $   7,530    $   6,791
                                                              =========    =========    =========

       Properties at end of year
           Land                                               $      42    $      41    $      36
           Buildings and building equipment                         702          640          600
           Machinery and equipment                                6,757        6,315        5,819
           Construction in progress                                 603          534          336
                                                              ---------    ---------    ---------

       Total                                                  $   8,104    $   7,530    $   6,791
                                                              =========    =========    =========


                                       39


   40


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

       ACCUMULATED DEPRECIATION



       (Dollars in millions)                                     1997          1996         1995
                                                                                     
       Balance at beginning of year                           $   4,010    $   3,742    $   3,483
           Provision for depreciation                               327          314          308
           Deductions                                              (114)         (46)         (49)
                                                              ---------    ---------    ---------

       Balance at end of year                                 $   4,223    $   4,010    $   3,742
                                                              =========    =========    =========


       Construction-period interest of $295 million, $257 million, and $229
       million, reduced by accumulated depreciation of $125 million, $111
       million, and $97 million, is included in cost of properties at December
       31, 1997, 1996, and 1995, respectively.

4.     EQUITY INVESTMENTS AND OTHER NONCURRENT ASSETS AND LIABILITIES

       Eastman has a 50% interest in Genencor International, a joint venture
       engaged in developing, manufacturing, and marketing industrial enzymes
       and other fine and specialty chemicals, accounted for under the equity
       method and included in other noncurrent assets. At December 31, 1997 and
       1996, Eastman's equity in the joint venture was $142 million and $138
       million, respectively. The Company guarantees a portion of the joint
       venture's third-party borrowings. Such guarantees are not considered
       material to Eastman. Management believes, based on current facts and
       circumstances and the joint venture's financial position, that the
       likelihood of a payment pursuant to such guarantee is remote.

       Eastman has a 50% interest in and serves as the operating partner in
       Primester, a joint venture formed in 1991 to construct and operate a
       production facility, accounted for under the equity method. The Company
       guarantees a portion of the principal amount of the joint venture's
       third-party borrowings; however, management believes, based on current
       facts and circumstances and the structure of the venture, that the
       likelihood of a payment pursuant to such guarantee is remote. At December
       31, 1997 and 1996, Eastman had a negative investment in the joint venture
       of $42 million and $44 million, respectively, representing the recognized
       portion of the venture's accumulated deficits and the debt guarantee that
       it has a commitment to fund, as necessary. Such amounts are included in
       other long-term liabilities. The Company provides certain utilities and
       general plant services to the joint venture. In return for Eastman
       providing those services, the joint venture paid Eastman a total of $39
       million in three equal installments in 1991, 1992, and 1993. Eastman is
       amortizing the deferred credit to earnings over a 10-year period.

       Eastman has entered into an agreement with a supplier that guarantees the
       Company's right to buy a specified quantity of a certain raw material
       annually through 2007 at prices determined by the pricing formula
       specified in the agreement. In return, the Company will pay a total of
       $239 million to the supplier through 1999 ($196 million and $175 million
       of which have been paid through December 31, 1997 and 1996,
       respectively). The Company defers and amortizes those costs over the
       15-year period during which the product is received. The Company began
       amortizing those costs in 1993 and has recorded accumulated amortization
       of $79 million and $64 million at December 31, 1997 and 1996,
       respectively.


                                       40

   41


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

5.     PAYABLES AND OTHER CURRENT LIABILITIES



                                                                                 DECEMBER 31,
       (Dollars in millions)                                                   1997         1996
                                                                                        
       Trade creditors                                                     $     281    $     312
       Accrued payrolls and vacation                                              99          101
       Accrued variable-incentive compensation                                    92          137
       Accrued pension liabilities                                               140            -
       Accrued taxes                                                              95           79
       Other                                                                     247          158
                                                                           ---------    ---------

       Total                                                               $     954    $     787
                                                                           =========    =========


6.     LONG-TERM BORROWINGS



                                                                                 DECEMBER 31,
       (Dollars in millions)                                                   1997         1996
                                                                                  
       6 3/8% notes due 2004                                               $     500    $     499
       7 1/4% debentures due 2024                                                495          495
       7 5/8% debentures due 2024                                                200          200
       7.60% debentures due 2027                                                 296            -
       Commercial paper and other                                                223          329
                                                                           ---------    ---------

       Total                                                               $   1,714    $   1,523
                                                                           =========    =========


Eastman has access to an $800 million revolving credit facility (the "Credit
Facility") expiring in December 2000. Although the Company does not have any
amounts outstanding under the Credit Facility, any such borrowings would be
subject to interest at varying spreads above quoted market rates, principally
LIBOR. The Credit Facility also requires a facility fee on the total commitment
that varies based on Eastman's credit rating. The annual rate for such fee was
0.075% in 1997, 1996, and 1995. The Credit Facility contains a number of
covenants and events of default, including the maintenance of certain financial
ratios. Eastman was in compliance with all such covenants for all periods.

Eastman utilizes commercial paper, generally with maturities of 90 days or less,
to meet its liquidity needs. The Company's commercial paper, supported by the
Credit Facility, is classified as long-term borrowings because the Company has
the ability and intent to refinance such borrowings long-term. As of December
31, 1997, the Company's commercial paper outstanding balance was $213 million,
at interest rates ranging between 6.10% and 6.90%. At December 31, 1996, a total
of $295 million of commercial paper was outstanding, at interest rates ranging
between 5.50% and 6.15%. The 7 5/8% debentures may be redeemed June 15, 2006, at
the option of their registered holders, at 100% of the principal amount plus
accrued interest to that date. During first quarter 1997 the Company issued $300
million of 7.60% debentures due February 1, 2027, and used the proceeds to repay
previously outstanding commercial paper borrowings outstanding at that time.


                                       41


   42


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


7.     SHAREOWNERS' EQUITY



       (Dollars in millions)                              1997             1996                1995
                                                                                            
       Common stock at par value                     $           1     $           1      $            1
                                                     -------------     -------------      --------------

       Paid-in capital
         Balance at beginning of year                           37                30                  22
         Additions                                              40                 7                   8
                                                     -------------     -------------      --------------
         Balance at end of year                                 77                37                  30
                                                     -------------     -------------      --------------

       Retained earnings                                     2,078             1,929               1,684
                                                     -------------     -------------      --------------

       Other
        Balance at beginning of year                            31                13                  14
        Change in cumulative translation
           adjustment                                          (52)               18                  (1)
        Change in unfunded minimum pension
           liability                                           (16)               --                  --
                                                     --------------    -------------      --------------
         Balance at end of year                                (37)               31                  13
                                                     --------------    -------------      --------------

       Treasury stock at cost                                 (366)             (359)               (200)
                                                     --------------    -------------      ---------------

       Total                                         $       1,753     $       1,639      $        1,528
                                                     =============     =============      ==============

       Shares of common stock issued
         Balance at beginning of year                   83,386,459        83,250,683          83,067,368
         Issued for employee compensation
            and benefit plans                              758,213           135,776             183,315
                                                     -------------     -------------      --------------
         Balance at end of year                         84,144,672        83,386,459          83,250,683
                                                     =============     =============      ==============


       The Company has authority to issue 400 million shares of all classes of
       stock, of which 50 million may be preferred stock, par value $0.01 per
       share, and 350 million may be common stock, par value $0.01 per share.
       Eastman has issued no shares of preferred stock. The Company declared
       dividends of $1.76 per share in 1997, $1.72 per share in 1996, and $1.64
       per share in 1995.

       The Company established a benefit security trust in the fourth quarter,
       1997, to provide a degree of financial security for unfunded obligations
       under certain plans. The Company has contributed to the trust a warrant
       to purchase up to one million shares of common stock of the Company for
       par value. The warrant is exercisable by the trustee if the Company does
       not meet certain funding obligations, which obligations would be
       triggered by certain occurrences, including a change in control or
       potential change in control, as defined, or failure by the Company to
       meet its payment obligations under covered unfunded plans. Such warrant
       is excluded from the computation of diluted earnings per share because
       the conditions upon which the warrant is exercisable have not been met.

       The additions to paid-in capital for the three years are the result of
       exercises of stock options by employees and the issuance of shares to the
       Employee Stock Ownership Plan to settle Eastman Performance Plan
       obligations.

       The Company repurchased 140,801 shares of Eastman common stock at a cost
       of $8 million, 2,486,300 shares at a cost of $161 million, and 3,308,200
       shares at a cost of $200 million, in 1997, 1996, and


                                       42



   43


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

      1995, respectively. Repurchased common shares may be used to meet common
      stock requirements for benefit plans and other corporate purposes.
      Treasury stock at a cost of approximately $1 million (18,018 shares) and
      $2 million (27,972 shares) was reissued in 1997 and 1996, respectively.
      The Company's charitable foundation held 184,557 shares, 202,575 shares,
      and 230,547 shares of Eastman common stock at December 31, 1997, 1996,
      and 1995, respectively.

      For 1997, 1996, and 1995, respectively, the weighted average number of
      common shares outstanding used to compute basic earnings per share was
      78.1 million, 78.5 million, and 81.7 million and for diluted earnings per
      share was 78.8 million, 79.3 million, and 82.4 million, reflecting the
      effect of dilutive options outstanding. Certain options outstanding at
      the end of 1997, 1996, and 1995, respectively, were excluded in the
      computation of diluted earnings per share because the options' exercise
      prices were greater than average market price of the common shares.
      Excluded were options to purchase 790,324 shares of common stock at a
      range of prices from $59.00 to $74.25; 566,490 shares of common stock at
      a range of prices from $57.125 to $74.25; and 489,942 shares of common
      stock at a range of prices from $63.1875 to $68.9375 outstanding at the
      end of 1997, 1996, and 1995, respectively.

8.    STOCK OPTION AND COMPENSATION PLANS

      OMNIBUS PLAN

      Eastman's 1997 Omnibus Long-Term Compensation Plan (the "1997 Omnibus
      Plan"), which is substantially similar to and intended to replace the 1994
      Omnibus Long-Term Compensation Plan (the "1994 Omnibus Plan"), provides
      for grants to employees of nonqualified stock options, incentive stock
      options, tandem and freestanding stock appreciation rights, performance
      shares, and various other stock and stock-based awards. Certain of these
      awards may be based on criteria relating to Eastman performance as
      established by the Compensation and Management Development Committee of
      the Board of Directors. No new awards have been made under the 1994
      Omnibus Plan following the effectiveness of the 1997 Omnibus Plan.
      Outstanding grants and awards under the 1994 Omnibus Plan are unaffected
      by the replacement of the 1994 Omnibus Plan with the 1997 Omnibus Plan.
      The 1997 Omnibus Plan provides that options can be granted through April
      30, 2002, for the purchase of Eastman common stock at an option price not
      less than 50% of the per share fair market value on the date of the stock
      option's grant. Substantially all grants awarded under the 1994 Omnibus
      Plan and under the 1997 Omnibus Plan have been at option prices equal to
      the fair market value on the date of grant. Options generally become
      exercisable 50% one year after grant and 100% after two years and expire
      up to ten years after grant. There is a maximum of 7 million shares of
      common stock available for option grants and other awards during the term
      of the 1997 Omnibus Plan. The maximum number of shares of common stock
      with respect to one or more options and/or SARs that may be granted during
      any one calendar year under the 1997 Omnibus Plan to the Chief Executive
      Officer or to any of the next four most highly compensated executive
      officers (each, a "Covered Employee") is 200,000. The maximum fair market
      value of any awards (other than options and SARs) that may be received by
      a Covered Employee during any one calendar year under the 1997 Omnibus
      Plan is equal to the fair market value of 100,000 shares of common stock
      as of December 31 of the preceding year.

      DIRECTOR LONG-TERM COMPENSATION PLAN

      Eastman's 1994 Director Long-Term Compensation Plan (the "Director Plan")
      provides for grants of nonqualified stock options and restricted shares to
      nonemployee members of the Board of Directors upon the first day of the
      directors' initial term of service. The Director Plan provides that
      options can be granted through December 31, 1998, for the purchase of
      Eastman common stock at an option price not less than the stock's fair
      market value on the date of the grant. The options vest in 50% increments
      on the first two anniversaries of the grant date.


                                       43


   44


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


      NONEMPLOYEE DIRECTOR STOCK OPTION PLAN

      Eastman's 1996 Nonemployee Director Stock Option Plan provides for grants
      of nonqualified stock options to nonemployee members of the Board of
      Directors in lieu of all or a portion of each member's annual retainer.
      The Nonemployee Director Stock Option Plan provides that options may be
      granted for the purchase of Eastman common stock at an option price not
      less than the stock's fair market value on the date of grant. The options
      become exercisable 6 months after the grant date. The maximum number of
      shares of Eastman common stock available for grant under the Plan is
      150,000.

      STOCK OPTION BALANCES AND ACTIVITY

      The Company applies intrinsic value accounting for its stock option plans.
      If the Company had elected to recognize compensation expense based upon
      the fair value at the grant dates for awards under these plans consistent
      with the methodology prescribed by SFAS No. 123, the Company's net
      earnings and basic earnings per share would be reduced to the unaudited
      pro forma amounts indicated below:



      (Dollars in millions, except for per share amounts)       1997          1996         1995
                                                                                     
      Net earnings                          As reported       $     286    $     380    $     559
                                            Pro forma         $     285    $     375    $     558

      Basic earnings per share              As reported       $    3.66    $    4.84    $    6.84
                                            Pro forma         $    3.65    $    4.78    $    6.82



                                       44


   45



                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

       The fair value of each option is estimated on the grant date using the
       Black-Scholes option-pricing model, which requires input of highly
       subjective assumptions. Some of these assumptions used for grants in
       1997, 1996, and 1995, respectively, include: average expected volatility
       of 21.61%, 25.23%, and 26.07%; average expected dividend yield of 2.92%,
       2.56%, and 2.83%; and average risk-free interest rates of 6.14%, 5.76%,
       and 6.37%. An expected option term of 6 years for all periods was
       developed based on historical grant information. The expected term for
       reloads was considered as part of this calculation and is equivalent to
       the remaining term of the original grant at the time of reload.

       Because the Company's stock had been traded for a period less than the
       baseline expected term assumption, previous years' calculations have used
       monthly volatility factors for five peer companies. The Company's
       volatility is now considered consistent with the peer group; therefore,
       for 1997 and subsequent years, the Company's volatility factors will be
       utilized. For valuation purposes, an average volatility factor based on
       the calendar-year quarter in which the options were granted was utilized.

       Because the Company's employee stock options have characteristics
       significantly different from those of traded options, and because changes
       in the subjective input assumptions can materially affect the fair value
       estimate, in management's opinion, the existing models do not necessarily
       provide a reliable single measure of the fair value of its employee stock
       options.

       A summary of the status of the Company's stock option plans is
       presented below:



                                                        1997                       1996                       1995
                                             ------------------------    -----------------------   ------------------------
                                                         WEIGHTED-                   WEIGHTED-                WEIGHTED-
                                                          AVERAGE                     AVERAGE                   AVERAGE
                                             OPTIONS   EXERCISE PRICE   OPTIONS   EXERCISE PRICE  OPTIONS   EXERCISE  PRICE
                                             -------   --------------   -------   --------------  -------   ---------------
                                                                                          
       Outstanding at beginning
         of year                            3,216,437     $   47        2,850,532     $   45      2,492,745     $    41

         Granted                              623,735         60          542,591         55        566,679          62
         Exercised                            123,964         40          176,686         40        208,892          40
         Forfeited or canceled                      -          -                -          -              -           -
                                            ----------    ------       ----------     ------     ----------     -------
       Outstanding at end
         of year                            3,716,208     $   50        3,216,437     $   47      2,850,532     $    45
                                            =========                   =========                 =========

       Options exercisable at
         year-end                           2,842,573                   2,461,995                 1,406,400
                                            =========                   =========                 =========
       Weighted-average fair
         value of options granted
           during the year                                $14.65                      $14.66                    $ 17.60

       Available for grant at end
         of year                            8,766,755                   2,384,543                 2,915,741
                                            =========                   =========                 =========



                                       45


   46


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


       The following table summarizes information about stock options
outstanding at December 31, 1997:



                                          OPTIONS OUTSTANDING                               OPTIONS EXERCISABLE
                          -----------------------------------------------------      --------------------------------
                            NUMBER        WEIGHTED-AVERAGE                            NUMBER
           RANGE OF       OUTSTANDING         REMAINING        WEIGHTED-AVERAGE      EXERCISABLE     WEIGHTED-AVERAGE
       EXERCISE PRICES    AT 12/31/97      CONTRACTUAL LIFE     EXERCISE PRICE       AT 12/31/97      EXERCISE PRICE
       ---------------    -----------     -----------------    ----------------      -----------     ----------------
                                                                                      
           $31-$40           357,357            3.4 years              $34               357,357             $34
             43-44         1,692,686            6.1                     43             1,692,686              43
             48-63         1,103,017            8.1                     57               254,690              53
             64-74           563,148            7.4                     65               537,840              65
                           ---------                                                  ----------
           $31-$74         3,716,208            6.6                    $50             2,842,573             $47
                           =========                                                  ==========



       EMPLOYEE STOCK OWNERSHIP PLAN

       The Company sponsors a defined contribution employee stock ownership plan
       (the "ESOP"), which is a qualified plan under Section 401(a) of the
       Internal Revenue Code. Eastman anticipates that it will direct a portion
       of the compensation of all U.S. employees to the ESOP. The Company also
       sponsors an employee stock ownership plan, which is substantially similar
       to the ESOP, for its international employees. Allocated shares in the
       ESOP totaled 2,289,826, 1,887,003, and 1,488,436 as of December 31, 1997,
       1996, and 1995, respectively.

       Compensation expense is measured based on the fair value of the shares
       contributed to or committed to be contributed to the ESOP. The shares are
       allocated to participant accounts and held by the ESOP until distributed
       to the employees at a future date, such as on the date of termination or
       retirement. Dividends on shares held by the ESOP are charged to retained
       earnings. All shares held by the ESOP are treated as outstanding in
       computing earnings per share.

       EASTMAN PERFORMANCE PLAN

       The Eastman Performance Plan (the "EPP") places a portion of each
       employee's annual compensation at risk and provides a lump-sum payment to
       plan participants based on the Company's financial performance. Certain
       portions of such payments, which are approved annually by Eastman's Board
       of Directors, are directed to the Company's ESOP. Charges under the EPP
       were $81 million, $131 million, and $229 million for 1997, 1996, and
       1995, respectively. Of these amounts, approximately $36 million in each
       year was directed to the Company's ESOP.

       ANNUAL PERFORMANCE PLAN

       Eastman's managers and executive officers participate in an Annual
       Performance Plan (the "APP"), which places a portion of annual cash
       compensation at risk based upon Company performance as measured by
       specified annual goals. Charges under the APP for 1997, 1996, and 1995
       were $11 million, $6 million, and $10 million, respectively.


                                       46


   47


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

9.     INCOME TAXES

       Components of earnings before income taxes and the provision for U.S.
       and other income taxes follow:



       (Dollars in millions)                                     1997          1996         1995
                                                                                     
       Earnings (loss) before income taxes
         United States                                        $     541    $     679    $     825
         Outside the United States                                  (95)         (72)          74
                                                              ----------   ----------   ---------

       Total                                                  $     446    $     607    $     899
                                                              =========    =========    =========

       Provision (benefit) for income taxes
         United States
           Current                                            $     134    $     190    $     291
           Deferred                                                  14           19          (12)
         Non-United States
           Current                                                    6            4           30
           Deferred                                                  (8)         (12)           2
         State and other
           Current                                                   13           25           30
           Deferred                                                   1            1           (1)
                                                              ---------    ---------    ---------

       Total                                                  $     160    $     227    $     340
                                                              =========    =========    =========



       Differences between the provision for income taxes and income taxes
       computed using the U.S. federal statutory income tax rate follow:



       (Dollars in millions)                                     1997          1996         1995
                                                                                     
       Amount computed using the statutory rate               $     156    $     212    $     315
       State income taxes                                             9           17           19
       Foreign rate variance                                         (4)          13            3
       Foreign sales corporation benefit                             (8)         (14)         (14)
       Other                                                          7           (1)          17
                                                              ---------    ---------    ---------

       Provision for income taxes                             $     160    $     227    $     340
                                                              =========    =========    =========



                                       47


   48


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


       The significant components of deferred tax assets and liabilities follow:



                                                                                 DECEMBER 31,
       (Dollars in millions)                                                   1997         1996
                                                                                        
       Deferred tax assets
         Postemployment obligations                                        $     292    $     263
         Payroll and related items                                                51           49
         Inventories                                                              17           13
         Deferred revenue                                                         19           21
         Miscellaneous reserves                                                   40           33
         Preproduction and start-up costs                                          8           18
         Other                                                                    36           17
                                                                           ---------    ---------

       Total                                                               $     463    $     414
                                                                           =========    =========

       Deferred tax liabilities
         Depreciation                                                      $     728    $     677
         Other                                                                    30           25
                                                                           ---------    ---------

       Total                                                               $     758    $     702
                                                                           =========    =========



       Unremitted earnings of subsidiaries outside the United States totaling
       $25 million at December 31, 1997, are considered to be reinvested
       indefinitely. If remitted, they would be substantially free of additional
       tax. It is not practicable to determine the deferred tax liability for
       temporary differences related to those unremitted earnings.

       Current income taxes payable totaling $53 million and $34 million are
       included in current liabilities at December 31, 1997 and 1996,
       respectively.


10.    FAIR VALUE OF FINANCIAL INSTRUMENTS



                                                        DECEMBER 31, 1997         DECEMBER 31, 1996
                                                       RECORDED       FAIR       RECORDED       FAIR
       (Dollars in millions)                            AMOUNT        VALUE       AMOUNT        VALUE
                                                                                      
       Long-term borrowings                          $   1,714    $   1,800     $  1,523     $  1,515
       Foreign exchange contracts                           62          149           74           63


       Eastman uses the following methods and assumptions in estimating its
       fair-value disclosures for financial instruments:

       Long-term borrowings

       The Company has based the fair value for fixed-rate borrowings on current
       interest rates for comparable securities. The Company's floating-rate
       borrowings approximate fair value.


                                       48


   49


                   EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES
                                        
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

       Foreign exchange contracts

       The Company estimates the fair value of its foreign exchange contracts
       based on dealer-quoted market prices of comparable instruments.

       Other financial instruments

       Because of the nature of all other financial instruments, recorded
       amounts approximate fair value. In the judgment of management, exposure
       to third-party guarantees is remote and the potential earnings impact
       pursuant to such guarantees is insignificant.

       DERIVATIVE FINANCIAL INSTRUMENTS HELD OR ISSUED FOR PURPOSES OTHER THAN
       TRADING

       Eastman had currency options with maturities of not more than 5 years to
       exchange various foreign currencies for U.S. dollars in the aggregate
       notional amount of $1.275 billion and $1.536 billion at December 31, 1997
       and 1996, respectively. The net unrealized gain (loss) deferred on such
       options was $87 million and $(11) million as of December 31, 1997 and
       1996, respectively. Those amounts, based on dealer-quoted prices,
       represent the estimated gain (loss) that would have been recognized had
       those hedges been liquidated at estimated market value on the last day of
       each year presented.

       The Company is exposed to credit loss in the event of nonperformance by
       counterparties on foreign exchange contracts but anticipates no such
       nonperformance. The Company minimizes such risk exposure by limiting the
       counterparties to major international banks and financial institutions.
       Concentrations of credit risk with respect to trade accounts receivable
       are generally diversified because of the large number of entities
       constituting the Company's customer base and their dispersion across many
       different industries and geographies.

11.    COMMITMENTS

       LEASE COMMITMENTS

       Eastman leases facilities, principally property, machinery, and
       equipment, under cancelable, noncancelable, and month-to-month operating
       leases. Future lease payments, reduced by sublease income, follow:



       (Dollars in millions)
                                                    
       Year ending December 31,
              1998                                     $    61
              1999                                          49
              2000                                          28
              2001                                          24
              2002                                          18
              2003 and beyond                               63
                                                       -------

       Total minimum payments required                 $   243
                                                       =======


       If certain operating leases are terminated by the Company, it guarantees
       a portion of the residual value loss, if any, incurred by the lessors in
       disposing of the related assets. Management believes, based on current
       facts and circumstances and current values of such equipment, that a
       material payment pursuant to such guarantees is remote.


                                       49


   50


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

       RENTAL EXPENSE



       (Dollars in millions)                                     1997          1996         1995
                                                                                     
       Gross rentals                                          $      81    $      66    $      60
       Less:  Sublease income                                         1            2           12
                                                              ---------    ---------    ---------

       Total                                                  $      80    $      64    $      48
                                                              =========    =========    =========



       CAPITAL EXPENDITURES AND OTHER COMMITMENTS

       Eastman anticipates total capital expenditures in 1998 will be between
       $550 million and $600 million and depreciation expense is expected to be
       approximately $350 million. The Company had various purchase commitments
       at the end of 1997 for materials, supplies, and energy incident to the
       ordinary conduct of business. These commitments total approximately $800
       million. Eastman has other long-term commitments relating to joint
       venture agreements as described in Note 4.

12.    RETIREMENT PLANS

       Eastman maintains defined benefit plans that provide eligible employees
       with retirement benefits calculated based on years of service and
       generally on the employees' final average compensation as defined in the
       plans. Benefits are paid to employees by insurance companies or from
       trust funds. Plan contributions are made as permitted by laws and
       regulations.

       Pension coverage for employees of Eastman's international operations is
       provided, to the extent deemed appropriate, through separate plans. The
       Company systematically provides for obligations under such plans by
       depositing funds with trustees, under insurance policies, or by book
       reserves. Total pension funds and accruals for non-U.S. plans less
       pension prepayments and deferred charges exceed the actuarially computed
       value of vested benefits under such plans as of the beginning of 1997 and
       1996.

       Eastman participated in Kodak's U.S. defined benefit pension plans
       covering substantially all U.S. employees prior to the spin-off. In
       connection with the spin-off, Eastman assumed the share of Kodak's U.S.
       defined benefit pension plan obligations relating primarily to active
       employees as of the date of the spin-off, while Kodak retained
       responsibility for pension obligations of substantially all retired U.S.
       employees.

       The components of net periodic pension cost for Eastman's U.S. defined
       benefit pension plans follow:



       (Dollars in millions)                                     1997          1996         1995
                                                                                     
       Service cost                                           $      49    $      49    $      35
       Interest cost                                                103           92           76
       Return on plan assets                                       (137)        (175)        (116)
       Net amortization                                              39           87           39
                                                              ---------    ---------    ---------
       Total U.S. pension cost                                $      54    $      53    $      34
                                                              =========    =========    =========


       Eastman's worldwide net pension cost was $59 million, $57 million, and
       $38 million in 1997, 1996, and 1995, respectively.

       See Note 14 for discussion of partial settlement/curtailment of pension
       and other postemployment benefit liabilities.


                                       50


   51


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

       The status of the Company's U.S. defined benefit pension plans follows:



                                                                                 DECEMBER 31,
       (Dollars in millions)                                                   1997         1996
                                                                                        
       Vested benefit obligation                                           $     978    $   1,029
                                                                           =========    =========

       Accumulated benefit obligation                                      $   1,081    $   1,119
                                                                           =========    =========

       Projected benefit obligation                                        $   1,345    $   1,410
       Market value of assets                                                    857        1,210
                                                                           ---------    ---------
       Projected benefits in excess of plan assets                               488          200
       Unrecognized net loss                                                    (226)         (70)
       Unrecognized net transition asset                                          35           57
       Unrecognized prior service cost                                           (49)         (30)
                                                                           ---------    ---------

       Accrued pension cost                                                $     248    $     157
                                                                           =========    =========


       The plans' assets are principally listed stocks.

       The assumptions used to develop the projected benefit obligation for the
       Company's U.S. pension plans follow:



                                                                                   DECEMBER 31,
                                                                                1997         1996
                                                                                         
       Discount rate                                                            7.25%        7.75%
       Salary increase rate                                                     4.00%        4.00%
       Long-term rate of return on plan assets                                  9.50%        9.50%



13.    OTHER POSTEMPLOYMENT COSTS

       Eastman provides life insurance and health care benefits for eligible
       retirees, and health care benefits for retirees' eligible survivors. In
       general, Eastman provides those benefits to retirees eligible under the
       Company's U.S. pension plans.

       Eastman and Kodak agreed that Kodak would retain the postretirement
       health and life insurance benefit obligations of substantially all U.S.
       retirees at the date of the spin-off. As a result, Eastman has no
       liability recorded for expected postretirement health and life insurance
       benefit costs for substantially all of its employees who retired through
       year-end 1993 while Eastman was a wholly owned business of Kodak.


                                       51

   52


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

       The following tables set forth the status of the Company's U.S. plans at
       December 31, 1997 and 1996:



                                                                            DECEMBER 31, 1997
                                                                    HEALTH        LIFE
       (Dollars in millions)                                         CARE       INSURANCE      TOTAL
                                                                                         
       Accumulated postretirement benefit obligation
         Retirees                                                 $     300     $     52     $    352
         Fully eligible active plan participants                         55            -           55
         Other active plan participants                                 136           41          177
                                                                  ---------     --------     --------
         Total accumulated postretirement benefit
           obligation                                                   491           93          584
       Plan assets at fair value                                         27            6           33
                                                                  ---------     --------     --------

       Accumulated postretirement benefit obligation
         in excess of plan assets                                 $     464     $     87          551
                                                                  =========     ========

       Unrecognized prior service cost                                                             49

       Unrecognized net loss                                                                       98
                                                                                             --------

       Accrued postretirement benefit cost                                                   $    502
                                                                                             ========


                                                                            DECEMBER 31, 1996
                                                                    HEALTH        LIFE
       (Dollars in millions)                                         CARE       INSURANCE       TOTAL
                                                                                         
       Accumulated postretirement benefit obligation
         Retirees                                                 $      87     $     15     $    102
         Fully eligible active plan participants                         93            -           93
         Other active plan participants                                 198          113          311
                                                                  ---------     --------     --------
         Total accumulated postretirement benefit
           obligation                                                   378          128          506
       Plan assets at fair value                                         20            5           25
                                                                  ---------     --------     --------

       Accumulated postretirement benefit obligation
         in excess of plan assets                                 $     358     $    123          481
                                                                  =========     ========

       Unrecognized net loss                                                                        6
                                                                                             --------
       Accrued postretirement benefit cost                                                   $    475
                                                                                             ========



                                       52


   53


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

       The net periodic postretirement benefit cost follows:



                                                                    HEALTH        LIFE
       (Dollars in millions)                                         CARE       INSURANCE       TOTAL
                                                                                         
       1997
       Service cost                                               $       6     $      3     $      9
       Interest cost                                                     31            7           38
       Return on plan assets                                             (1)          (3)          (4)
                                                                  ---------     --------     --------
       Net periodic postretirement benefit cost                   $      36     $      7     $     43
                                                                  =========     ========     ========

       1996
       Service cost                                               $       7     $      5     $     12
       Interest cost                                                     25            9           34
       Return on plan assets                                             (1)           -           (1)
                                                                  ---------     --------     --------
       Net periodic postretirement benefit cost                   $      31     $     14     $     45
                                                                  =========     ========     ========

       1995
       Service cost                                               $       8     $      3     $     11
       Interest cost                                                     27            8           35
       Return on plan assets                                             (1)           -           (1)
                                                                  ---------     --------     --------
       Net periodic postretirement benefit cost                   $      34     $     11     $     45
                                                                  =========     ========     ========


       To estimate the Company's postretirement benefit cost, health care costs
       were assumed to increase 8.00% for 1998, with the rate of increase
       declining to 5.00% by 2002 and thereafter. The discount rate and salary
       increase rate were assumed to be 7.25% and 4.00% at December 31, 1997,
       7.75% and 4.00% at December 31, 1996, and 7.25% and 4.00% at December 31,
       1995. If the health care cost trend rates were increased by one
       percentage point, the Company's accumulated postretirement health care
       benefit obligation as of December 31, 1997, would increase by $75
       million, while the net periodic postretirement health care benefit cost
       would increase by $8 million. See Note 14 for discussion of partial
       settlement/curtailment of pension and other postemployment benefit
       liabilities.

       A few of Eastman's non-U.S. operations have supplemental health benefit
       plans for certain retirees, the cost of which is not significant to the
       Company.


14.    EARLY RETIREMENT CHARGE

       In fourth quarter 1997 the Company recorded a $62 million ($40 million
       after tax) charge for the partial settlement/curtailment of pension and
       other postemployment benefit liabilities. The charge resulted from the
       early retirement of approximately 1,700 employees, a majority of whom
       chose to take their retirement benefits as a lump sum. No special
       payments or incentives were offered.


                                       53

   54



                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

15.    SEGMENT INFORMATION

       INDUSTRY SEGMENTS

       Eastman is an international chemical company that manufactures and sells
       a broad range of products. The Company categorizes its business into
       three segments: Specialty and Performance, Core Plastics, and Chemical
       Intermediates. The Company believes no significant changes to current
       reporting will be required as a result of SFAS No. 131, "Disclosures
       about Segments of an Enterprise and Related Information," which is
       effective for 1998.

       The Specialty and Performance segment contains products that are sold to
       customers that base their buying decisions principally on product
       performance attributes. The major products in this segment include
       specialty plastics, coatings and paint raw materials, fine chemicals,
       performance chemicals, and fibers. Targeted markets for this segment are
       diverse and include medical, electronics, pharmaceutical, agricultural,
       recreation, consumer durables, photographic, additives for fibers and
       plastics, adhesives, sealants, food and beverages, nutrition, cosmetics,
       textiles, construction, coatings, inks, paints, filters, and specialty
       plastic applications. Competitive factors for this segment include price,
       reliability of supply, customer service, environmental responsibility,
       and technical competence. Coatings and paint raw materials are sold
       primarily to North American industrial concerns. The principal markets
       for Eastman's fine chemicals are largely U.S. photographic, agricultural,
       and pharmaceutical companies. Acetate tow is sold worldwide to the
       tobacco industry for use in cigarette filters. The operations of Holston
       Defense Corporation are included in the Specialty and Performance segment
       and do not have a significant impact on the financial position or results
       of operations of the Company.

       The Core Plastics segment includes the Company's two major plastics
       products, EASTAPAK polymers and TENITE polyethylene, as well as cellulose
       esters and polyesters. These container and packaging products share
       similar physical characteristics and compete based on price and
       integrated manufacturing capabilities. Polyester plastics are sold to
       soft-drink and other packaging manufacturers principally in North
       America, Europe, and Latin America. Polyethylene is sold generally to
       North American industries.

       The Chemical Intermediates segment contains industrial intermediate
       chemicals that are produced based on the Company's oxo chemistry
       technology and chemicals-from-coal technology and are sold to customers
       operating in mature markets in which multiple sources of supply exist.
       They are sold generally in large volume mostly to North American
       industries, with increasing focus in Southeast Asia. These products are
       targeted at markets for industrial additives, agricultural chemicals,
       esters, pharmaceuticals, and vinyl compounding. Competitive factors
       include price, reliability of supply, and integrated manufacturing
       capability. Favorable cost position, proprietary products, and improving
       standards of living worldwide are key value drivers for this segment.


                                       54


   55


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS




       (Dollars in millions)                                     1997          1996         1995
                                                                                     
       SALES
         Specialty and Performance                            $   2,607    $   2,657    $   2,647
         Core Plastics                                            1,338        1,409        1,685
         Chemical Intermediates                                     733          716          708
                                                              ---------    ---------    ---------
           Total                                              $   4,678    $   4,782    $   5,040
                                                              =========    =========    =========

       OPERATING EARNINGS (LOSS)
         Specialty and Performance                            $     416(1) $     519    $     433
         Core Plastics                                              (56)(1)       (1)         347
         Chemical Intermediates                                     146(1)       145          184
                                                              ---------    ---------    ---------
           Total                                              $     506    $     663    $     964
                                                              =========    =========    =========

       ASSETS
         Specialty and Performance                            $   3,019    $   2,887    $   2,776
         Core Plastics                                            2,188        1,854        1,598
         Chemical Intermediates                                     571          525          498
                                                              ---------    ---------    ---------
           Total                                              $   5,778    $   5,266    $   4,872
                                                              =========    =========    =========

       DEPRECIATION EXPENSE
         Specialty and Performance                            $     172    $     174    $     178
         Core Plastics                                              123          109           96
         Chemical Intermediates                                      32           31           34
                                                              ---------    ---------    ---------
           Total                                              $     327    $     314    $     308
                                                              =========    =========    =========

       CAPITAL EXPENDITURES
         Specialty and Performance                            $     227    $     302    $     176
         Core Plastics                                              390          388          215
         Chemical Intermediates                                     132           99           55
                                                              ---------    ---------    ---------
           Total                                              $     749    $     789    $     446
                                                              =========    =========    =========


(1)Operating earnings for 1997 reflect the $62 million ($40 million after tax)
charge for partial settlement/curtailment of pension and other postemployment
benefit liabilities. The charge was allocated to segments as follows: Specialty
and Performance, $34 million; Core Plastics, $18 million; and Chemical
Intermediates, $10 million. See Note 14 for a discussion of the charge.


                                       55


   56


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

       GEOGRAPHIC SEGMENTS

       Sales are reported in the geographic area where they originate. Transfers
       among geographic areas are made on a basis intended to reflect the market
       value of the products, recognizing prevailing market prices and
       distributor discounts. Export sales to unaffiliated customers from the
       United States were $626 million in 1997, $687 million in 1996, and $698
       million in 1995.



       (Dollars in millions)             United States     Europe      Other Areas     Eliminations   Consolidated
                                                                                       
1997
Sales                                        $3,500         $ 755          $ 423                         $4,678 
Transfers among geographic areas                798            18             74          $  (890)           -- 
                                             ------         -----          -----          -------        ------ 
                                                                                                                
    Total sales                              $4,298         $ 773          $ 497          $  (890)       $4,678 
                                             ======         =====          =====          =======        ====== 
                                                                                                                
Operating earnings (losses)                  $  580         $ (51)         $ (37)         $    14        $  506 
                                             ======         =====          =====          =======        ====== 
                                                                                                                
Assets at end of year                        $5,628         $ 805          $ 625          $(1,280)       $5,778 
                                             ======         =====          =====          =======        ====== 
                                                                                                                
                                                                                                                
1996 
Sales                                        $3,674         $ 735          $ 373                        $ 4,782
Transfers among geographic areas                785            27             55          $  (867)           -- 
                                             ------         -----          -----          -------        ------ 
                                                                                                                
    Total sales                              $4,459         $ 762          $ 428          $  (867)       $4,782 
                                             ======         =====          =====          =======        ====== 
                                                                                                                
Operating earnings (losses)                  $  717         $ (36)         $ (31)         $    13        $  663 
                                             ======         =====          =====          =======        ====== 
                                                                                                                
Assets at end of year                        $5,076         $ 582          $ 424          $  (816)       $5,266 
                                             ======         =====          =====          =======        ====== 
                                                                                                                
                                                                                                                
1995
Sales                                        $3,864         $ 806          $ 370                         $5,040 
Transfers among geographic areas                806            50             17          $  (873)           -- 
                                             ------         -----          -----          -------        ------ 
                                                                                                                
    Total sales                              $4,670         $ 856          $ 387          $  (873)       $5,040 
                                             ======         =====          =====          =======        ====== 
                                                                                                                
Operating earnings                           $  881         $  47          $  25          $    11        $  964 
                                             ======         =====          =====          =======        ====== 
                                                                                                                
Assets at end of year                        $4,569         $ 508          $ 324          $  (529)       $4,872 
                                             ======         =====          =====          =======        ====== 



                                       56


   57


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


16.    SUPPLEMENTAL CASH FLOW INFORMATION

       Cash paid for interest and income taxes is as follows:



       (Dollars in millions)                                     1997          1996         1995
                                                                                        
       Interest (net of amounts capitalized)                    $  88         $  79        $  91
       Income taxes                                               131           236          364


       Cash flows from operating activities include gains (losses) from equity
       investments of $11 million, $(3) million, and $(6) million for 1997,
       1996, and 1995, respectively. Derivative financial instruments and
       related gains and losses are included in cash flows from operating
       activities. The effect on cash of foreign currency transactions and
       exchange rate changes for all years presented was insignificant.

       In March 1997 the Company issued 611,962 shares of its common stock with
       a market value of $34 million to its Employee Stock Ownership Plan as
       partial settlement of the Company's Eastman Performance Plan payout. This
       noncash transaction is not reflected in the Consolidated Statements of
       Cash Flows. The Consolidated Statements of Cash Flows do not separately
       reflect certain Eastman assets acquired and liabilities assumed through
       noncash transactions.

17.    HOLSTON DEFENSE CORPORATION

       Holston Defense Corporation ("Holston"), a wholly owned subsidiary of the
       Company, has, as its sole business, managed the government-owned Holston
       Army Ammunition Plant in Kingsport, Tennessee (the "Facility") since 1942
       under a series of contracts with the Department of Army (the "DOA").
       Holston is currently managing the Facility under a contract that expires
       on December 31, 1998 (the "Contract"), unless such management is
       otherwise extended by the DOA pursuant to the terms of the Contract or by
       agreement between the parties. The Contract generally provides for
       payment of a management fee to Holston and reimbursement by the DOA of
       defined costs incurred by Holston for the operation of the Facility.
       Holston's operating results historically have been insignificant to the
       Company's consolidated sales and earnings.

       The DOA has undertaken to accept bids from qualified companies to manage
       the Facility upon termination of the Contract under terms and conditions
       substantially different from those of the Contract. During fourth quarter
       1997 the DOA advised Holston that, because of Holston's position on the
       DOA's proposed terms and conditions, it was not a qualified participant
       in the bidding process. The bidding process is still in progress, and its
       outcome and impact on Holson's continued management of the Facility is
       currently uncertain. Consequently, management does not believe that it is
       reasonably assured that Holston will not continue to manage the Facility
       in some capacity.

       Pension and other postemployment benefits are currently provided to
       Holston's present and past employees under the terms of Holston's plans.
       Termination of Holston's management of the Facility, if it occurs, could
       result in termination payments to Holston's then-current employees and
       require additional funding for the acceleration of obligations under the
       pension and other postretirement benefit plans (such payments and
       additional funding referred to collectively as "Termination Costs").
       Actual Termination Costs would depend upon a number of factors, all of
       which are not yet known to the Company. If the Company subsequently were
       to determine that it is probable that it will incur Termination Costs,
       then the Company would, in accordance with generally accepted accounting
       principles, be required to recognize the Termination Costs as
       liabilities, and payments and reimbursements from the DOA, where
       appropriate, as receivables. While the exact amount of Termination Costs
       cannot be determined at this time, the Company estimates the range of
       additional liabilities which it would recognize if Holston's management
       of the Facility were to terminate on December 31, 1998, without giving
       effect to any


                                       57


   58



                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS


       payment or reimbursement, to be approximately $50 million to $75 million.
       The difference, if any, between any such liabilities and receivables
       would result in a charge to then-current earnings. In the event of
       termination of Holston's management of the Facility, delays in the
       payment or reimbursement of all or portions of the Termination Costs may
       require the Company to advance funds to pay such costs.

       Although the DOA's position with respect to similar contracts is that it
       has no legal liability for unfunded postretirement benefit costs, other
       than pension obligations, and the DOA may disagree with the specific
       amount of other Termination Costs, it is the opinion of the Company and
       its management, based on the Contract terms, applicable law, and legal
       and equitable precedents, that substantially all of the Termination Costs
       would be paid by the DOA or recovered from the government in related
       proceedings, and that the amounts, if any, not paid or recovered, or the
       advancement of funds by the Company pending such reimbursement or
       recovery, should not have a material adverse effect on the consolidated
       financial position of the Company.

18.    ENVIRONMENTAL MATTERS

       Certain Eastman manufacturing sites generate hazardous and nonhazardous
       wastes, of which the treatment, storage, transportation, and disposal are
       regulated by various governmental agencies. In connection with the
       cleanup of various hazardous waste sites, the Company, along with many
       other entities, has been designated a potentially responsible party
       ("PRP") by the U.S. Environmental Protection Agency under the
       Comprehensive Environmental Response, Compensation and Liability Act,
       which potentially subjects PRPs to joint and several liability for such
       cleanup costs. In addition, the Company will be required to incur costs
       for environmental remediation and closure/postclosure under the federal
       Resource Conservation and Recovery Act. Because of expected sharing of
       costs, the availability of legal defenses, and the Company's preliminary
       assessment of actions that may be required, the Company does not believe
       its liability for these environmental matters, individually or in the
       aggregate, will be material to Eastman's consolidated financial position,
       results of operations, or competitive position.

       The Company's environmental protection and improvement cash expenditures
       were approximately $220 million, $175 million, and $150 million in 1997,
       1996, and 1995, respectively, including investments in construction,
       operations, and development.

 19.   LEGAL MATTERS

       The Company's operations are parties to or targets of lawsuits, claims,
       investigations, and proceedings, including product liability, personal
       injury, patent, commercial, contract, environmental, antitrust, health
       and safety, and employment matters, which are being handled and defended
       in the ordinary course of business. While the Company is unable to
       predict the outcome of these matters, it does not believe, based upon
       currently available facts, that the ultimate resolution of any of such
       pending matters will have a material adverse effect on the Company's
       business, financial position, or results of operations.


                                       58


   59


                    EASTMAN CHEMICAL COMPANY AND SUBSIDIARIES

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

20.    QUARTERLY SALES AND EARNINGS DATA - UNAUDITED



       (Dollars in millions, except per share amounts)

       1997                                            1ST QTR.    2ND QTR.   3RD QTR.    4TH QTR. (1)
                                                                                  
       Sales                                           $   1,171  $   1,208  $   1,145  $   1,154
       Operating earnings                                    134        157        148         67
       Earnings before income taxes                          114        141        148         43
       Provision for income taxes                             42         51         52         15
       Net earnings                                           72         90         96         28
       Basic earnings per share (2)                          .93       1.15       1.23        .36
       Diluted earnings per share (2)                        .92       1.14       1.22        .35


       1996                                            1ST QTR.    2ND QTR.   3RD QTR.   4TH QTR.
                                                                                  
       Sales                                           $   1,261  $   1,241  $   1,167  $   1,113
       Operating earnings                                    191        190        169        113
       Earnings before income taxes                          178        177        156         96
       Provision for income taxes                             66         65         60         36
       Net earnings                                          112        112         96         60
       Basic earnings per share (2)                         1.41       1.42       1.23        .77
       Diluted earnings per share (2)                       1.39       1.41       1.22        .77


       -------------------------
        (1) Fourth quarter 1997 operating data reflects a charge of $62 million
       ($40 million after tax) resulting from partial settlement/curtailment of
       pension and other postemployment benefit liabilities. See Note 14 for a
       discussion of the charge.

       (2) Each quarter is calculated as a discrete period; the sum of the four
       quarters may not equal the calculated full-year amount. Earnings per
       share for prior periods have been restated to conform to requirements of
       the new accounting standard effective for periods ending after December
       15, 1997.


                                       59


   60


ITEM 9.    CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING
           AND FINANCIAL DISCLOSURE

None.


                                       60

   61
                                    PART III

ITEM 10.     DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

The material under the heading "Election of Directors -- General" in the 1998
Proxy Statement is incorporated by reference herein in response to this Item.
Certain information concerning executive officers of the Company is set forth
under the heading "Executive Officers of the Company" in Part I of this Annual
Report on Form 10-K.


ITEM 11.     EXECUTIVE COMPENSATION

The material under the headings "Election of Directors -- Compensation of
Directors" in the 1998 Proxy Statement is incorporated by reference herein in
response to this Item.  In addition, the material under the heading "Executive
Compensation and Benefits" in the 1998 Proxy Statement is incorporated by
reference herein in response to this Item, except for the material under the
subheadings " -- Compensation and Management Development Committee Report on
Executive Compensation" and " -- Performance Graph," which are not incorporated
by reference herein.


ITEM 12.     SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
             MANAGEMENT

The material under the headings "Stock Ownership of Directors and Executive
Officers--Common Stock" and "Stock Ownership of Certain Beneficial Owners" in
the 1998 Proxy Statement is incorporated by reference herein in response to
this Item.


ITEM 13.     CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS

There are no transactions or relationships since the beginning of the last
completed fiscal year required to be reported in response to this Item.





                                       61
   62

                                    PART IV

ITEM 14.     EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K



      (a)  1.    Consolidated financial statements:                                           Page
                                                                                        

                 Management's responsibility for financial statements                           32

                 Report of independent accountants                                              33

                 Consolidated statements of earnings and retained earnings                      34

                 Consolidated statements of financial position                                  35

                 Consolidated statements of cash flows                                          36

                 Notes to consolidated financial statements                                37 - 59


            2. Financial statement schedules

               All schedules have been omitted because they are not applicable 
               or because the required information is shown in the financial 
               statements or notes thereto.

            3. Exhibits filed as part of this report are listed in the Exhibit 
               Index appearing on page 65.

      (b)   Reports on Form 8-K

            During the quarter ended December 31, 1997, no reports on Form 8-K
were filed.

      (c)  The Exhibit Index and required Exhibits to this report are included
beginning at page 65.

      (d)  There are no applicable financial statement schedules required to be
filed as part of this report.





                                       62
   63

                                   SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

                                              Eastman Chemical Company
                                             
                                             
                                             
                                              By:/s/ Earnest W. Deavenport, Jr.
                                                 ------------------------------
                                                    Earnest W. Deavenport, Jr.
                                                    Chairman of the Board and
                                                    Chief Executive Officer

Date:  March 6, 1998

Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
registrant and in the capacities and on the date indicated.



        SIGNATURE                                TITLE                             DATE
        ---------                                -----                             ----
                                                                      
PRINCIPAL EXECUTIVE OFFICER:



/s/ Earnest W. Deavenport, Jr.              Chairman of the                 March 6, 1998
- ------------------------------              Board and Chief                                   
   Earnest W. Deavenport, Jr.              Executive Officer
                                                            



PRINCIPAL FINANCIAL OFFICER:



/s/ H. Virgil Stephens                 Senior Vice President and            March 6, 1998
- ------------------------------          Chief Financial Officer                               
   H. Virgil Stephens                   



PRINCIPAL ACCOUNTING OFFICER:



/s/ Patrick R. Kinsey                     Vice President and                March 6, 1998
- ------------------------------                Comptroller                                     
   Patrick R. Kinsey                          






                                       63
   64



SIGNATURE                                        TITLE                             DATE
- ---------                                        -----                             ----
                                                                      
DIRECTORS:



/s/ R. Wiley Bourne, Jr.                    Vice Chairman                   March 6, 1998
- ------------------------------               of the Board                               
R. Wiley Bourne, Jr.                        and Executive 
                                            Vice President
                                                          


/s/ H. Jesse Arnelle                           Director                     March 6, 1998
- ------------------------------                                                          
H. Jesse Arnelle



/s/ Calvin A. Campbell, Jr.                    Director                     March 6, 1998
- ------------------------------                                                           
Calvin A. Campbell, Jr.



/s/ Jerry E. Dempsey                           Director                     March 6, 1998
- ------------------------------                                                          
Jerry E. Dempsey



/s/ John W. Donehower                          Director                     March 6, 1998
- ------------------------------                                                           
John W. Donehower



/s/ Lee Liu                                    Director                     March 6, 1998
- ------------------------------                                                          
Lee Liu



/s/ Marilyn R. Marks                           Director                     March 6, 1998
- ------------------------------                                                          
Marilyn R. Marks



/s/ Gerald B. Mitchell                         Director                     March 6, 1998
- ------------------------------                                                          
Gerald B. Mitchell



/s/ John A. White                              Director                     March 6, 1998
- ------------------------------                                                                
John A. White






                                      64
   65

                                 EXHIBIT INDEX



Exhibit                                       Description                                                   Sequential
Number                                                                                                         Page
                                                                                                              Number
                                                                                                      
 3.01            Amended and Restated Certificate of Incorporation of Eastman Chemical Company
                 (incorporated herein by reference to Exhibit 3.01 to Eastman Chemical Company's
                 Registration Statement on Form S-1, File No. 33-72364, as amended (the "S-1"))

 3.02            Amended and Restated By-laws of Eastman Chemical Company, as amended February 3, 1998         69-78

 4.01            Form of Eastman Chemical Company Common Stock certificate (incorporated herein by
                 reference to Exhibit 3.02 to Eastman Chemical Company's Annual Report on Form 10-K for
                 the year ended December 31, 1993 (the "1993 10-K"))

 4.02            Stockholder Protection Rights Agreement dated as of December 13, 1993, between Eastman
                 Chemical Company and First Chicago Trust Company of New York, as Rights Agent
                 (incorporated herein by reference to Exhibit 4.4 to Eastman Chemical Company's
                 Registration Statement on Form S-8 relating to the Eastman Investment Plan, File No.
                 33-73810)

 4.03            Indenture, dated as of January 10, 1994, between Eastman Chemical Company and The Bank
                 of New York, as Trustee (the "Indenture") (incorporated herein by reference to Exhibit
                 4(a) to Eastman Chemical Company's current report on Form 8-K dated January 10, 1994
                 (the "8-K"))

 4.04            Form of 6 3/8% Notes due January 15, 2004 (incorporated herein by reference to Exhibit
                 4(c) to the 8-K)

 4.05            Form of 7 1/4% Debentures due January 15, 2024 (incorporated herein by reference to
                 Exhibit 4(d) to the 8-K)

 4.06            Officers' Certificate pursuant to Sections 201 and 301 of the Indenture (incorporated
                 herein by reference to Exhibit 4(a) to Eastman Chemical Company's Current Report on
                 Form 8-K dated June 8, 1994 (the "June 8-K"))

 4.07            Form of 7 5/8% Debentures due June 15, 2024 (incorporated herein by reference to
                 Exhibit 4(b) to the June 8-K)

 4.08            Form of 7.60% Debenture due February 1, 2027 (incorporated herein by reference to
                 Exhibit 4.08 to Eastman Chemical Company's Annual Report on Form 10-K for the year
                 ended December 31, 1996 (the "1996 10-K"))

 4.09            Officer's Certificate pursuant to Sections 201 and 301 of
                 the Indenture related to 7.60% Debentures due February 1, 2027 (incorporated herein by
                 reference to Exhibit 4.09 1996 10-K)





                                       65
   66

                                 EXHIBIT INDEX



Exhibit                                       Description                                                        Sequential
Number                                                                                                              Page
                                                                                                                   Number
                                                                                                           
 4.10            Credit Agreement, dated as of December 19, 1995 (the "Credit Agreement") among Eastman
                 Chemical Company, the Lenders named therein, and The Chase Manhattan Bank, as Agent
                 (incorporated herein by reference to Exhibit 4.08 to Eastman Chemical Company's Annual
                 Report on Form 10-K for the year ended December 31, 1995 (the "1995 10-K"))

*10.01           Eastman Annual Performance Plan, as amended (incorporated herein by reference to
                 Exhibit 10.01 to the 1996 10-K)

*10.02           1994 Director Long-Term Compensation Plan, as amended (incorporated herein by
                 reference to Exhibit 10.02 to Eastman Chemical Company's Quarterly Report on Form 10-Q
                 for the quarter ended March 31, 1995)

*10.03           1994 Omnibus Long-Term Compensation Plan (incorporated herein by reference to Exhibit
                 10.03 to Eastman Chemical Company's Registration Statement on Form 10, originally
                 filed on November 26, 1993 (the "Form 10"))

*10.04           1996 Non-Employee Director Stock Option Plan, as amended (incorporated herein by
                 reference to Exhibit 10.02 to Eastman Chemical Company's Quarterly Report on Form 10-Q
                 for the quarter ended September 30, 1996 (the "September 30, 1996 10-Q"))

*10.05           Director Deferred Compensation Plan, as amended  (incorporated herein by reference to
                 Exhibit 10.05 to the 1996 10-K)

*10.06           Executive Deferred Compensation Plan, as amended (incorporated herein by reference to
                 Exhibit 10.06 to the 1996 10-K)

*10.07           Form of Executive Severance Agreements (incorporated herein by reference to Exhibit
                 10.06 to the 1995 10-K)

*10.08           Employment Agreement between Eastman Chemical Company and Harold L. Henderson 
                 (incorporated herein by reference to Exhibit 10.08 to the 1996 10-K)

*10.09           Eastman Excess Retirement Income Plan (incorporated herein by reference to Exhibit
                 10.10 to the Form 10)

*10.10           Eastman Unfunded Retirement Income Plan (incorporated herein by reference to Exhibit
                 10.11 to the Form 10)

*10.11           Eastman Employee Stock Ownership Plan Excess Plan (incorporated herein by reference to
                 Exhibit 10.11 to the 1996 10-K)



                                       66
   67
                                 EXHIBIT INDEX



Exhibit                                       Description                                                    Sequential
Number                                                                                                          Page
                                                                                                               Number
                                                                                                       
*10.12           Eastman 1995-1997 Long-Term Performance Subplan (as amended) of 1994 Omnibus Long-Term
                 Compensation Plan (incorporated by reference to Exhibit 10.05 to the September 30,
                 1996 10-Q)

*10.13           Eastman 1996-1998 Long-Term Performance Subplan (as amended) of 1994 Omnibus Long-Term
                 Compensation Plan (incorporated by reference to Exhibit 10.06 to the September 30,
                 1996 10-Q)

*10.14           Eastman 1997-1999 Long-Term Performance Subplan of
                 1994 Omnibus Long-Term Compensation Plan (incorporated herein by reference to Exhibit
                 10.15 to 1996 10-K)

*10.15           Eastman 1998-2000 Long-Term Performance Subplan of 1997 Omnibus Long-Term Compensation
                 Plan                                                                                            79-87

*10.16           1997 Omnibus Long-Term Compensation Plan (incorporated herein by reference to Appendix
                 A to Eastman Chemical Company's definitive 1997 Annual Meeting Proxy Statement filed
                 pursuant to Regulation 14A)

*10.17           Award Notice for Price-Vesting Stock Option Granted to CEO under 1997 Omnibus Long-
                 Term Compensation Plan (incorporated herein by reference to Exhibit 10.01 to Eastman
                 Chemical Company's Form 10-Q for the quarter ended September 30, 1997)

*10.18           Eastman Chemical Company Benefit Security Trust dated December 24, 1997                        88-106              

10.19            Contribution Agreement, dated as of December 9, 1993, between Eastman Kodak Company
                 and Eastman Chemical Company (incorporated herein by reference to Exhibit 10.07 to the
                 S-1)

10.20            General Assignment, Assumption and Agreement Regarding Litigation, Claims and Other
                 Liabilities, dated as of December 31, 1993, between Eastman Kodak Company and Eastman
                 Chemical Company (incorporated herein by reference to Exhibit 10.08 to the S-1)

10.21            Tax Sharing and Indemnification Agreement, dated as of December 31, 1993, between
                 Eastman Kodak Company and Eastman Chemical Company (incorporated herein by reference
                 to Exhibit 10.09 to the S-1)

10.22            Intellectual Property Agreement Non-Imaging, dated as of December 31, 1993, between
                 Eastman Kodak Company and Eastman Chemical Company (incorporated herein by reference
                 to Exhibit 10.12 to the S-1)


                                       67
   68

                                 EXHIBIT INDEX



Exhibit                                       Description                                               Sequential
Number                                                                                                     Page
                                                                                                          Number
                                                                                                  
10.23            Imaging Chemicals License Agreement, dated as of December 31, 1993, between Eastman
                 Kodak Company and Eastman Chemical Company (incorporated herein by reference to
                 Exhibit 10.13 to the S-1)

12.01            Statement re Computation of Ratios of Earnings to Fixed Charges                            107                     

21.01            Subsidiaries of the Company                                                            108-109
                                                                                                               
23.01            Consent of Independent Accountants                                                         110
                                                                                                               
27.01            Financial Data Schedule (for SEC use only)                                                 111
                                                                                                               
99.01            Supplemental Business Segment Information                                                  112






- ------------------------------
*   Management contract or compensatory plan or arrangement filed pursuant to
Item 601(b)(10)(iii) of Regulation S-K.





                                       68